Carl J. Fichtenbaum , MD

Dr. Fichtenbaum's expertise is in clinical research in infectious diseases, with a focus on HIV infection and the intersection of HIV and cardiovascular disease. Dr. Fichtenbaum is Principal Investigator of the Infectious Diseases Research Unit at UC.  He is board certified by the American Board of Internal Medicine and Infectious Diseases. Dr. Fichtenbaum has been elected as a Fellow to the American College of Physicians, HIV Medical Association, and Infectious Diseases Society of America. His published works include approximately more than 175 articles, 135 abstracts and various reviews, book chapters and letters.

Bachelor's Degree: University of Missouri 1983 (Biology)

Medical Degree: University of Missouri 1985

Residency : Bridgeport Hospital 1989 (Internal Medicine / Pediatrics)

Chief Medical Residency : Bridgeport Hospital 1990 (Chief Medical Residency)

Fellowship: Yale University School of Medicine 1991 (AIDS Clinical Fellow)

Fellowship: Barnes Hospital/Washington University School of Medicine 1994 (Infectious Diseases)

Fellowship: National Institute of Drug Abuse 1994

American Board of Internal Medicine (Infectious Disease) (Certification Date: 11-10-1994 ) - (Recertification Date: to 12-31-2014 )

American Board of Internal Medicine (Certification Date: 09-13-1989 ) - (Recertification Date: to 11-03-2004 )

Infectious Disease

Pediatrics

Hepatitis C Virus (HCV)

HIV/AIDS (Human immunodeficiency virus)

Infectious Diseases

Internal Medicine

Pediatrics

HIV, STDs And Other Selected Infectious Diseases

1989 -1990 Clinical Instructor, Yale University School of Medicine,

1990 -1991 Post-Doctoral Fellow, Yale University School of Medicine,

1991 -1994 Fellow in Medicine, Washington University School of Medicine,

1993 -1996 Instructor of Medicine, Washington University School of Medicine,

1996 -1999 Assistant Professor of Medicine, Washington University School of Medicine,

1999 -2006 Associate Professor of Clinical Medicine, University of Cincinnati,

2006 - Professor of Clinical Medicine, University of Cincinnati,

2012 -2023 Associate Chairman for Translational Research, University of Cincinnati, Department of Internal Medicine

2023 - Vice Chair, Clinical Research, Department of Internal Medicine, University of Cincinnati,

Grant: #1 U01 AI069513 Investigators:Fichtenbaum, Forrester 12-01-2007 -11-30-2013 NIH/NIAID AIDS Clinical Trials Group Role:PI $997,057 Active

Grant: #1 T01 AI1068524 Investigators:Chougnet, Fichtenbaum 08-01-2006 -07-31-2011 NIEHS Role of Regulatory T Cells in HIV Infection Role:Investigator $14,549 Active

Grant: #5 H76HA0111 Investigators:Kaul, Fichtenbaum, Forrester, Haglund 01-01-2007 -12-31-2011 DHHS/HRSA Cincinnati Health Network, Ryan White Title III Funds Role:Co-PI $582,753 Active

Grant: #5 U01 NS032228-12 Investigators:Clifford, Fichtenbaum 12-01-2009 -11-30-2011 National Institute of Neurological Disorders & Stroke Washington University Neurological AIDS Research Consortium Role:Investigator $11,000 Active

Grant: #1 R56A1087462-01A1 Investigators:Lyons, Fichtenbaum 09-15-2010 -08-13-2011 NIH/NIAID Transmission Network Targeting Adjunct to Emergency Department Screening Role:Investigator $19,794 Active

Grant: #U10 DA013732 Investigators:Somoza, Fichtenbaum 09-15-2010 -08-31-2011 NIDA Clinical Trials Network Ohio Valley Node Role:Investigator $2,807,592 Active

Grant: #000059 Investigators:Fichtenbaum, Carl 01-01-2006 -12-31-2006 Health Resources and Services Administration Community HIV comprehensive Care Program Role:PI $547,000.00 Closed Level:Federal

Grant: #CHMC 103666 Investigators:Fichtenbaum, Carl 08-01-2006 -07-31-2011 National Institute of Allergy and Infectious Diseases Role of Regulatory T Cells in HIV Infection Role:PI $134,932.00 Closed Level:Federal

Investigators:Fichtenbaum, Carl 04-01-2002 -03-01-2005 Research Triangle Institute RTI AIDS/Cancer Cohort Study Role:PI $8,410.00 Closed Level:Private Non-Profit

Grant: #CHMC 430 / R01 AI056927 Investigators:Fichtenbaum, Carl 01-01-2005 -12-31-2009 National Institute of Allergy and Infectious Diseases CD40 Ligand Dysregulation and HIV Pathogenesis Role:PI $148,850.00 Closed Level:Federal

Grant: #7-R01-DA-09825-04-A0-S0-E0 Investigators:Fichtenbaum, Carl 08-01-1999 -07-31-2000 National Institute on Drug Abuse Epidemiology and Outcome of STDS in Drug Users Role:PI $62,734.00 Closed Level:Federal

Grant: #SRS 004193 Investigators:Fichtenbaum, Carl; Sharma, Sonia 04-05-2007 -06-30-2008 Bristol-Myers Squibb Co. Lower HDL and Elevated Triglycerides Predict HIV-Associated Lipoatrophy Role:PI $15,000.00 Closed Level:Industry

Grant: #BRS-ACURE-Q-06-0000164 (Master Agreement) / U01 AI068636 Investigators:Feinberg, Judith; Fichtenbaum, Carl 07-01-2006 -05-31-2013 National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group Network Role:PI $424,732.44 Closed Level:Federal

Grant: #CRB-DCR01-S-09-00319 / HHSN272200900001/2/3I Investigators:Feinberg, Judith; Fichtenbaum, Carl 11-01-2009 -03-31-2013 National Institute of Allergy and Infectious Diseases SSS Master Agreement Role:PI $304,161.85 Active Level:Federal

Grant: #CRB-UCLA-S-10-00045 / R01 HL095132 Investigators:Fichtenbaum, Carl 06-01-2009 -06-30-2012 National Heart, Lung and Blood Institute Cardiovascular, Anthropometric, and Skeletal Effects of Anti-Retroviral Initiation with Tenofovir/Emtricitabine plus Atazanavir/Ritonavir, Darunavir/Ritonavir or Raltegravir Role:PI $56,840.00 Active Level:Federal

Grant: #WU-10-197 Investigators:Fichtenbaum, Carl 12-01-2009 -11-30-2011 National Institute of Neurological Disorders and Stroke Neurologic AIDS Research Consortium - Washington University Sub Role:PI $17,270.00 Closed Level:Federal

Grant: #CRB-UWAS1-S-11-0027 / HL095126 Investigators:Fichtenbaum, Carl 07-01-2010 -06-30-2012 National Heart, Lung and Blood Institute Carotid Artery Intima Media Thickness and Brachial Artery Imaging Role:PI $6,260.00 Active Level:Federal

Grant: #BRS-ACURE-S-12-002363 Investigators:Fichtenbaum, Carl 01-01-2012 -05-31-2014 Aids Clinical Trials Group Network A Phase 2b, Double-Blind, Placebo-Controlled, Exploratory Randomized Trial to Determine the Bone, Immunologic, Virologic, and Neurocognitive Effects of a Novel Maravirco-Containing Role:PI $4,640.00 Active Level:Private Non-Profit

Grant: #BRS-ACURE-S-12-00214 Investigators:Fichtenbaum, Carl 06-01-2011 -05-31-2013 Bristol-Myers Squibb Co. A Prospective Randomized Pilot Trial of High Dose Vitamin D and Calcium for Bone Health in HIV Infected Individuals Initiating Highly Active Antiretroviral Therapy (HAART) Role:PI $1,500.00 Active Level:Industry

Grant: #BRS-ACURE-S-12-000604-002301 Investigators:Fichtenbaum, Carl 06-01-2011 -05-31-2012 National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group Network Role:PI $393.00 Closed Level:Federal

Grant: #CHN Sub \ H76HAO0111 Investigators:Feinberg, Judith; Fichtenbaum, Carl; Forrester, Jennifer; Grubbs, Peter; Haglund, Lisa; Johnson, Kay; Kaul, Pamposh 04-01-2012 -03-31-2014 Health Resources and Services Administration Community HIV Comprehensive Care Program Role:Collaborator $1,165,506.00 Active Level:Federal

Grant: #CRB-SSS-S-12-00296 Investigators:Fichtenbaum, Carl 05-01-2012 -05-31-2013 Merck Sharp & Dohme Corp Aids Clinical Trial Group -A5309 - Patient Remunerations Role:PI $4,710.00 Active Level:Industry

Grant: #108364 Investigators:Fichtenbaum, Carl 06-01-2012 -12-31-2013 National Institute of Allergy and Infectious Diseases ACTG PIF Year 6 Supplement Role:PI $14,604.25 Awarded Level:Federal

Grant: #UC-2013-01/HHSN272201300013I Investigators:Fichtenbaum, Carl 09-15-2013 -07-28-2020 National Institute of Allergy and Infectious Diseases Sexually Transmitted Infections Clinical Trials Group (STI-CTG) Role:PI $16,291.00 Awarded Level:Federal

Grant: #RES508646 / UM1 AI069501 Investigators:Fichtenbaum, Carl 12-10-2013 -11-30-2020 National Institute of Allergy and Infectious Diseases AIDS Clinical Trial Group Role:PI $322,151.00 Awarded Level:Federal

Grant: #110208 / UM1AI068636 Investigators:Fichtenbaum, Carl 01-01-2014 -05-31-2014 National Institute of Allergy and Infectious Diseases ACTG Protocol Funds Role:PI $120,953.00 Awarded Level:Federal

Grant: #110406 Investigators:Fichtenbaum, Carl 12-02-2013 -06-30-2014 Gilead Sciences, Inc. Long Term Effects of ARV Therapy on Change in the Bone Mineral Denisty in Infected Subjects Role:PI $1,316.00 Active Level:Federal

Grant: #224838 / U01 HL123336 Investigators:Fichtenbaum, Carl 08-08-2014 -08-30-2019 National Heart, Lung and Blood Institute Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE) Role:PI $12,193.00 Active Level:Federal

Grant: #109135 / R01 HL117713 Investigators:Fichtenbaum, Carl 12-02-2013 -06-30-2014 National Heart, Lung and Blood Institute ACTG Protocol Funds A5314 Role:PI $27,050.00 Active Level:Federal

Grant: #110208-Protocol A / UM1 AI068636 Investigators:Fichtenbaum, Carl 06-01-2014 -11-30-2014 National Institute of Allergy and Infectious Diseases ACTG Protocol Funding for "A" studies Role:PI $123,651.93 Active Level:Federal

Grant: #CRM Sub / HHSN272201300013I Investigators:Fichtenbaum, Carl 10-01-2014 -09-30-2015 National Institute of Allergy and Infectious Diseases Sexually Transmitted Infections Clinical Trials Group (STI-CTG) Role:PI $16,506.77 Active Level:Federal

Grant: #224883 / R01 HL122177 Investigators:Fichtenbaum, Carl 08-15-2014 -05-31-2015 National Institute of Allergy and Infectious Diseases Effect of Low Dose Methotrexate on Arterial Inflammation in HIV- A5314 Role:PI $33,598.83 Active Level:Federal

Grant: #225707_U01 HL123336 Investigators:Fichtenbaum, Carl 08-08-2014 -04-30-2020 National Institutes of Health REPRIEVE A5332 and A5333 Role:PI $10,000.00 Awarded Level:Federal

Grant: #111670 / UM1 AI068636 Investigators:Fichtenbaum, Carl 12-01-2014 -11-30-2015 National Institute of Allergy and Infectious Diseases ACTG Protocol Funding "PF" Year 9 Role:PI $391,608.00 Active Level:Federal

Grant: #RES509526 / 2UM1AI059501-09 Yr 2 Investigators:Fichtenbaum, Carl 12-01-2014 -11-30-2015 National Institute of Allergy and Infectious Diseases AIDS Clinical Trial Group Role:PI $431,625.00 Active Level:Federal

Grant: #CW ACTG Core / AI069501 Investigators:Fichtenbaum, Carl 12-01-2015 -11-30-2016 National Institute of Allergy and Infectious Diseases AIDS Clinical Trial Group - Competitive Renewal Role:PI $374,060.00 Active Level:Federal

Grant: #SASC Investigators:Fichtenbaum, Carl 12-01-2015 -11-30-2016 National Institute of Allergy and Infectious Diseases ACTG Scientific Agenda Steering Committee (SASC) Support Role:PI $12,000.00 Active Level:Federal

Grant: #110238 / AI068636 Investigators:Fichtenbaum, Carl 03-23-2015 -11-30-2015 National Institute of Allergy and Infectious Diseases Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE) Role:PI $10,821.00 Awarded Level:Federal

Grant: #137281\R01AG033057 Investigators:Fichtenbaum, Carl 09-01-2015 -08-31-2016 Cincinnati Children's Hospital Medical Center Homeostasis and function of regulatory T cells in aging Role:PI $31,600.00 Awarded Level:Private Non-Profit

Grant: #FHI360 CA-HPTN-UC-1 sub UM1AI068619 Investigators:Fichtenbaum, Carl 05-01-2016 -11-30-2016 National Institute of Allergy and Infectious Diseases HPTN 083: A Phase 2b?3 Double Blind Safety and Efficacy Study of Injectable Cabotegravir Compared to Daily Oral Tenofovir Disoproxil Fumarate/Emtricitabine (TDF/FTC), for Pre-Exposure Prophylaxis in H Role:PI $.00 Active Level:Federal

Grant: #CRB-SSS-S-16-004872 Investigators:Fichtenbaum, Carl 11-01-2015 -06-30-2016 Leidos Biomedical Research, Inc. Basic Order Agreement No. 11XS088, Task Order #Q7 Role:PI $3,400.00 Closed Level:Industry

Grant: #SSS CRB-SSS-S-16-004913 sub Leidos Bio 11XS088 sub NIAID Investigators:Fichtenbaum, Carl 06-20-2016 -09-30-2017 National Institute of Allergy and Infectious Diseases A Randomized Double-Blind, Phase 3 Study Comparing the Efficacy and Safety of High-Titer versus Low-Titer Anti-Influenza Immune Plasma for the Treatment of Severe Influenza A Role:PI $15,600.00 Active Level:Federal

Grant: #RES511290_AI068501 Investigators:Fichtenbaum, Carl 08-01-2016 -11-30-2016 National Institute of Allergy and Infectious Diseases Case Western Equipment suplement Role:PI $35,068.00 Active Level:Federal

Grant: #CWRU FHI360 CA-HPTN-UC-1 sub UM1 AI068619 Investigators:Fichtenbaum, Carl 05-01-2016 -11-30-2017 National Institute of Allergy and Infectious Diseases HPTN 083: A Phase 2b?3 Double Blind Safety and Efficacy Study of Injectable Cabotegravir Compared to Daily Oral Tenofovir Disoproxil Fumarate/Emtricitabine (TDF/FTC), for Pre-Exposure Prophylaxis in H Role:PI $218,000.00 Awarded Level:Federal

Grant: #Rep. Women Investigators:Fichtenbaum, Carl 03-01-2016 -02-28-2017 National Institute of Allergy and Infectious Diseases Women’s Ancillary Study - Cardiovascular Disease Risk in HIV-infected Women: Sex-Specific Mechanisms of Risk and Risk Reduction among REPRIEVE Trial Participants Role:PI $2,409.22 Awarded Level:Federal

Grant: #Rep Kidney / R01 DK108438 Investigators:Fichtenbaum, Carl 07-01-2016 -06-30-2017 National Inst of Diabetes and Digestive and Kidney Disease Effect of Pitavastatin on Kidney Function in HIV-infected Person (R01DK108438-02) - REPRIEVE Kidney Study Role:PI $35,425.00 Awarded Level:Federal

Grant: #RES511634 ACTG Core / AI069501 Investigators:Fichtenbaum, Carl 12-01-2016 -11-30-2017 National Institute of Allergy and Infectious Diseases AIDS Clinical Trial Group - Competitive Renewal Role:PI $374,060.00 Active Level:Federal

Grant: #116678 / R01 AG054366 Investigators:Fichtenbaum, Carl 08-01-2016 -05-31-2017 National Institute on Aging Pitavastatin to REduce Physical Function Impairment and Frailty in HIV (PREPARE) Role:PI $16,275.00 Awarded Level:Federal

Grant: #CWRU sub FHI360 HPTN 083 sub NIAID UM1 AI068619 Investigators:Fichtenbaum, Carl 01-01-2017 -11-30-2022 National Institute of Allergy and Infectious Diseases HPTN 083 is a Phase 2b/3 Safety and Efficacy Study of Injectable Cabotegravir Compared to Daily Oral Tenofovir Disoproxil Fumarate/Emtricitabine (TDF/FTC), for Pre-Exposure Prophylaxis Role:PI $1,259,830.00 Awarded Level:Federal

Grant: #CWRU RES512468 sub U01AI131295 Investigators:Fichtenbaum, Carl 08-09-2017 -07-31-2018 National Institute of Allergy and Infectious Diseases Resetting immune homeostasis: a non-invasive approach towards HIV eradication Role:PI $170,915.00 Active Level:Federal

Grant: #RES512798 / UM1 AI069501 Investigators:Fichtenbaum, Carl 12-01-2017 -11-30-2018 National Institute of Allergy and Infectious Diseases ACTG Core Funds Role:PI $374,030.00 Active Level:Federal

Grant: #232251 / AI123001 Investigators:Fichtenbaum, Carl 03-01-2018 -02-28-2019 National Institute of Allergy and Infectious Diseases Women’s Ancillary Study - Cardiovascular Disease Risk in HIV-infected Women: Sex-Specific Mechanisms of Risk and Risk Reduction among REPRIEVE Trial Participants Role:PI $2,939.20 Awarded Level:Federal

Grant: #RES513645 / U01AI131295 Investigators:Fichtenbaum, Carl 08-01-2018 -07-31-2019 National Institute of Allergy and Infectious Diseases Resetting immune homeostasis: a non-invasive approach towards HIV eradication Role:PI $77,276.00 Awarded Level:Federal

Grant: #RES513848 ACTG Core-PF, HPTN PF / UM1AI069501 Investigators:Fichtenbaum, Carl 12-01-2018 -11-30-2019 National Institute of Allergy and Infectious Diseases ACTG Core Funds Role:PI $511,735.00 Awarded Level:Federal

Grant: #RES513819 / ViiV Investigators:Fichtenbaum, Carl 01-01-2017 -11-30-2018 VIIV HEALTHCARE COMPANY HPTN 083- University of Cincinnati (ViiV) Role:PI $735,241.00 Awarded Level:Industry

Grant: #110007 AEC_UM1AI068636 Investigators:Fichtenbaum, Carl 12-01-2017 -11-30-2018 National Institute of Allergy and Infectious Diseases ACTG Executive Committe Role:PI $10,000.00 Awarded Level:Federal

Grant: #1560 G WA886 Rep Chair / AI068636 Investigators:Fichtenbaum, Carl 12-01-2018 -11-30-2019 National Institute of Allergy and Infectious Diseases Leadership and Operations Center (LOC), AIDS Clinical Trials Group (ACTG) [UM1AI068636] Vice Co-Chair on A5332 Role:PI $16,021.00 Awarded Level:Federal

Grant: #1560 G WA885 AEC / AI068636 Investigators:Fichtenbaum, Carl 12-01-2018 -11-30-2020 National Institute of Allergy and Infectious Diseases Leadership and Operations Center (LOC), AIDS Clinical Trials Group (ACTG) [UM1AI068636] Role:PI $12,000.00 Awarded Level:Federal

Grant: #1560 B WA785 Protocol A / UM1AI068636 Investigators:Fichtenbaum, Carl 12-01-2018 -11-30-2019 National Institute of Allergy and Infectious Diseases Leadership and Operations Center (LOC), AIDS Clinical Trials Group (ACTG) [UM1AI068636] Role:PI $325,903.00 Awarded Level:Federal

Grant: #1560BWB787 PREPARE / R01AG054366 Investigators:Fichtenbaum, Carl 06-15-2018 -05-31-2019 National Institutes of Health Pitavastatin to REduce Physical Function Impairment and Frailty in HIV (PREPARE) Role:PI $18,034.44 Active Level:Federal

Grant: #RES514327 / AI131295 Investigators:Fichtenbaum, Carl 08-01-2019 -07-31-2020 National Institute of Allergy and Infectious Diseases Resetting immune homeostasis: a non-invasive approach towards HIV eradication Role:PI $93,300.00 Awarded Level:Federal

Grant: #Rep Kidney / DK108438 Investigators:Fichtenbaum, Carl 07-01-2018 -06-30-2021 National Inst of Diabetes and Digestive and Kidney Disease Effect of Pitavastatin on Kidney Function in HIV-infected Person (R01DK108438-02) - REPRIEVE Kidney Study Role:PI $42,774.53 Awarded Level:Federal

Grant: #Janssen 63623872FLZ3001 sub BARDA HHSO10020500014C Investigators:Fichtenbaum, Carl 10-01-2019 -09-30-2020 Biomedical Advanced Research and Development Authority A Phase 3 Randomized, Double-blink, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safet of Pimodivir in Combination with the Standard-of-care Treatment in Adolescent, Adult,.... Role:PI $85,487.60 Awarded Level:Federal

Grant: #PF Sal / AI068619 Investigators:Fichtenbaum, Carl 12-01-2018 -11-30-2019 National Institute of Allergy and Infectious Diseases HPTN PF Salary supplement Role:PI $40,740.00 Awarded Level:Federal

Grant: #ACTG CORE / AI069501 Investigators:Fichtenbaum, Carl; Huaman, Moises; Sherman, Kenneth 12-01-2019 -11-30-2020 National Institute of Allergy and Infectious Diseases ACTG Core Funds, PF & HPTN Role:PI $1,110,207.00 Awarded Level:Federal

Grant: #CoVPN 3502 - UM1AI068619 Investigators:Fichtenbaum, Carl 07-01-2020 -11-30-2021 National Institute of Allergy and Infectious Diseases CoVPN 3502/ R10933-10987-COV-2069: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Assessing the Efficacy and Safety of Anti-Spike SARS-CoV-2 Monoclonal Antibodies in Preventing SARS-CoV Role:PI $237,750.00 Awarded Level:Federal

Grant: #FHI360-CoVPN 3001/ UM1AI068619 Investigators:Fichtenbaum, Carl; Powers-Fletcher, Margaret 07-01-2020 -06-30-2022 National Institute of Allergy and Infectious Diseases CoVPN 3001: Phase 3, SARS-CoV-2 Vaccine (Moderna TX, Inc.) Role:PI $3,269,500.00 Awarded Level:Federal

Grant: #Unknown Investigators:Fichtenbaum, Carl; Powers-Fletcher, Margaret 07-01-2020 -11-30-2020 National Institute of Allergy and Infectious Diseases COVID-19 Prevention Network (CoVPN) Role:PI $380,075.01 Active Level:Federal

Grant: #PO20002964 / UM1AI068619 CoVPN 3501 Investigators:Fichtenbaum, Carl 08-01-2020 -07-31-2021 National Institute of Allergy and Infectious Diseases A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of LY3819253 in Preventing SARS-CoV-2 Infection and COVID-19 in Skilled Nursing and Assisted Living Fac Role:PI $84,321.00 Active Level:Federal

Grant: #RES515323 / U01AI069501 Investigators:Fichtenbaum, Carl; Huaman, Moises 06-01-2020 -11-30-2020 National Institute of Allergy and Infectious Diseases ADMIN SUPPLEMENT for ACTG - CWRU Core & PF Role:PI $296,270.18 Awarded Level:Federal

Grant: #CWRU RES515587 / U01AI131295 Investigators:Fichtenbaum, Carl 08-01-2020 -09-30-2020 National Institute of Allergy and Infectious Diseases Resetting immune homeostasis: a non-invasive approach towards HIV eradication RPPR for 2020 Role:PI $224,390.00 Awarded Level:Federal

Grant: #1560 G YB694 / AI068636 Vice Chair Investigators:Fichtenbaum, Carl 12-01-2020 -11-30-2021 National Institute of Allergy and Infectious Diseases Leadership and Operations Center (LOC), AIDS Clinical Trials Group (ACTG) AEC Role:PI $8,057.00 Awarded Level:Federal

Grant: #1560 G YB310 / AI068636 AEC Investigators:Fichtenbaum, Carl 12-01-2020 -11-30-2021 National Institute of Allergy and Infectious Diseases Leadership and Operations Center (LOC), AIDS Clinical Trials Group (ACTG) [UM1AI068636] AEC Role:PI $4,920.00 Awarded Level:Federal

Grant: #ACTG Protocol A_AI068636 Investigators:Fichtenbaum, Carl 12-01-2020 -11-30-2027 National Institute of Allergy and Infectious Diseases Leadership and Operations Center (LOC), AIDS Clinical Trials Group (ACTG) [UM1AI068636] Protocol A Role:PI $508,600.00 Awarded Level:Federal

Grant: #RES515922_PO20001904 Investigators:Fichtenbaum, Carl 05-01-2020 -11-30-2020 Family Health International 360 HPTN Personal Protective Equipment – HPTN Studies (Cost Reimbursable) Role:PI $26,128.00 Awarded Level:Private Non-Profit

Grant: #Emory / AI131295 Investigators:Fichtenbaum, Carl 10-01-2020 -07-31-2021 National Institute of Allergy and Infectious Diseases Resetting immune homeostasis: a non-invasive approach towards HIV eradicationTransfer to Emory Role:PI 203634.35 Hold Level:Federal

Grant: #ACTG Core/PF / AI065901 Investigators:Fichtenbaum, Carl; Huaman Joo, Moises; Sherman, Kenneth 12-01-2020 -12-31-2021 National Institute of Allergy and Infectious Diseases ACTG competitive renewal Role:PI 378535.00 Active Level:Federal

Investigators:Fichtenbaum, Carl 08-01-2021 -07-31-2022 University of California, Los Angeles Doravirine for Persons with Excessive Weight Gain on Integrase Inhibitors and Tenofovir Alafenamide (The Do IT Study) Role:PI 7006.00 Hold Level:Higher Education

Grant: #RES / AI065901 Investigators:Fichtenbaum, Carl; Huaman Joo, Moises; Sherman, Kenneth 12-01-2021 -11-30-2022 National Institute of Allergy and Infectious Diseases ACTG Core 2021-22 Role:PI 1159303.57 Hold Level:Federal

Grant: #PO21002303 / UM1 AI068619 Investigators:Fichtenbaum, Carl 08-01-2021 -11-30-2021 National Institute of Allergy and Infectious Diseases HIV PREVENTION TRIALS NETWORK (HPTN) 083 OLE Role:PI 274824.00 Hold Level:Federal

Grant: #212483 Investigators:Fichtenbaum, Carl 10-04-2021 -10-03-2024 GlaxoSmithKline PLC (United Kingdom) A Phase IIb, randomized, double-blind, parallel-group study to assess the efficacy, safety, tolerability, and resistance profile of GSK3640254 in combination with dolutegravir compared to dolutegravir Role:PI 195200.05 Hold Level:Industry

Investigators:Fichtenbaum, Carl; Gakumo, Carrie; Kim, Minjin; Perazzo, Joseph 01-15-2022 -01-14-2024 Merck Sharp & Dohme Corp PARTNER (Participant Approaches to Research Techniques Nurture Engagement and Retention) Role:Collaborator 0.00 Hold Level:Industry

Grant: #mRNA-1273-P304 Investigators:Fichtenbaum, Carl 06-01-2022 -05-31-2025 ModernaTX, Inc. A Phase 3b, Open-Label, Safety and Immunogenicity Study of SARS-CoV-2 mRNA-1273 Vaccine in Adult Solid Organ Transplant Recipients and Healthy Controls Role:PI 734468.39 Hold Level:Industry

Grant: #GS-US-425-6143 Investigators:Fichtenbaum, Carl 02-01-2022 -02-01-2025 Gilead Sciences, Inc. A Phase 1b Randomized, Blinded, Placebo-Controlled, Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of GS-8588 in People with HIV-1 who are Virologic Role:PI 0.00 Hold Level:Industry

Grant: #Cornell 226628-14/ 4UH3HL154944-02 Investigators:Fichtenbaum, Carl -08-31-2023 National Heart, Lung and Blood Institute Doxycycline for Emphysema in People Living with HIV (The DEPTH Trial) Role:PI 0.00 Hold Level:Federal

Grant: #CHN / H76HA00111 Investigators:Fichtenbaum, Carl; Kaul, Pamposh; Robertson, Jaime 04-01-2022 -03-31-2023 Health Resources and Services Administration Ryan White Part C- Outpatient EIS Program Role:Collaborator 685326.00 Hold Level:Federal

Grant: #MGH 242757; 1UG3HL164285-01 Investigators:Fichtenbaum, Carl 05-01-2023 -04-30-2024 National Heart, Lung and Blood Institute REPRIEVE A5332 and A5333 Role:PI 0.00 Hold Level:Federal

Grant: #GS-US-544-5905 Investigators:Fichtenbaum, Carl 04-27-2023 -04-30-2026 Gilead Sciences, Inc. An Umbrella Phase 1b, Open-label, Multi Cohort Study to evaluate Safety, Pharmacokinetics, and Antiviral Activity of Novel Antiretrovirals in Participants with HIV-1. Role:PI 0.00 Hold Level:Industry

Grant: #CWRU ACTG; RES600754/ 5UM1AI069501-17 Investigators:Fichtenbaum, Carl; Huaman Joo, Moises; Perazzo, Joseph; Sherman, Kenneth 12-01-2022 -11-30-2023 National Institute of Allergy and Infectious Diseases CWRU ACTG; Case Clinical Trials Unit Role:PI 352710.00 Hold Level:Federal

Grant: #MK-8591A-053-5662 Investigators:Fichtenbaum, Carl 06-01-2023 -06-15-2026 Merck Sharp & Dohme LLC A Phase 3, Randomized, Active-Controlled, Double-Blind Clinical Study to Evaluate the Antiretroviral Activity, Safety, and Tolerability of Doravirine/Islatravir (DOR/ISL 100 mg/0.25 mg) Once-Daily in Role:PI 1387799.55 Hold Level:Industry

Grant: #CWRU; tba/ AI069501 Investigators:Fichtenbaum, Carl -11-30-2023 National Institute of Allergy and Infectious Diseases CWRU admin supplement Role:PI 0.00 Hold Level:Federal

Grant: #PO21000338_UM1AI068619 CoPVN 3005 Sanofi Investigators:Fichtenbaum, Carl; Huaman Joo, Moises 12-01-2020 -05-10-2021 National Institute of Allergy and Infectious Diseases CoVPN 3005 (Efficacy, Immunogenicity, and Safety of SARS-CoV-2 Recombinant Protein Vaccine with Adjuvant in Adults 18 Years of Age)Sanofi vaccine trial Role:Collaborator 0.00 Closed Level:Federal

Grant: #MGH; 243119/ 1UG3HL164285-01 Investigators:Fichtenbaum, Carl 05-01-2023 -04-30-2026 National Heart, Lung and Blood Institute Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE) Co-Chair Role:PI 23093.00 Hold Level:Federal

Investigators:Fichtenbaum, Carl 10-18-2023 -07-18-2028 GlaxoSmithKline PLC (United Kingdom) A Phase 2b Multicenter, Randomized, Open-Label Study Comparing the Efficacy, Safety, PK, and Tolerability of VH3810109, Administered Either Intravenously Or As A Subcutaneous Infusion with rHuPH20, in Role:PI 1144706.17 Hold Level:Industry

Grant: #15600000136252; Protocol A5415; 237424/ R01HL149516; Investigators:Fichtenbaum, Carl 09-01-2023 -08-31-2024 National Heart, Lung and Blood Institute ACTG Protocol Funds Subaward Agreement 15600000136252 - A5415 Role:PI 96522.00 Awarded Level:Federal

Investigators:Fichtenbaum, Carl 11-24-2024 -11-17-2029 Gilead Sciences, Inc. A Phase 3, Randomized, Active-controlled, Double-blind Study to Evaluate a Switch to an Oral Weekly Islatravir/Lenacapavir Regimen in People With HIV-1 Who Are Virologically Suppressed on Bictegravir/ Role:PI 0.00 Hold Level:Industry

Peer Reviewed Publications

Samineni, Divya; Fichtenbaum, Carl J (2010. ) Fenofibrate in the treatment of dyslipidemia associated with HIV infection.Expert opinion on drug metabolism & toxicology, , 6 (8 ) ,995-1004 More Information

Jacobson, Jeffrey M; Lalezari, Jacob P; Thompson, Melanie A; Fichtenbaum, Carl J; Saag, Michael S; Zingman, Barry S; D'Ambrosio, Paul; Stambler, Nancy; Rotshteyn, Yakov; Marozsan, Andre J; Maddon, Paul J; Morris, Stephen A; Olson, William C (2010. ) Phase 2a Study of the CCR5 Monoclonal Antibody PRO 140 Administered Intravenously to HIV-infected Adults.Antimicrobial agents and chemotherapy, , More Information

Fichtenbaum, Carl J (2010. ) Does antiretroviral therapy increase or decrease the risk of cardiovascular disease?.Current HIV/AIDS reports, , 7 (2 ) ,92-8 More Information

Murphy, Robert L; Berzins, Baiba; Zala, Carlos; Fichtenbaum, Carl; Dube, Michael P; Guaraldi, Giovanni; Torriani, Francesca; Belsey, Elizabeth; Mitchell, Carol; Stein, James H (2010. ) Change to atazanavir/ritonavir treatment improves lipids but not endothelial function in patients on stable antiretroviral therapy.AIDS (London, England), , 24 (6 ) ,885-90 More Information

Lyons, Michael S; Lindsell, Christopher J; Ruffner, Andrew H; Trott, Alexander T; Fichtenbaum, Carl J (2009. ) Relationship of self-reported prior testing history to undiagnosed HIV positivity and HIV risk. Current HIV research, , 7 (6 ) ,580-8

Nyakeriga, Alice M; Fichtenbaum, Carl J; Goebel, Jens; Nicolaou, Stella A; Conforti, Laura; Chougnet, Claire A (2009. ) Engagement of the CD4 receptor affects the redistribution of Lck to the immunological synapse in primary T cells: implications for T-cell activation during human immunodeficiency virus type 1 infection.Journal of virology, , 83 (3 ) ,1193-200 More Information

Fichtenbaum, Carl J (2009. ) Metabolic abnormalities associated with HIV infection and antiretroviral therapy. Current infectious disease reports, , 11 (1 ) ,84-92

Lyons, Michael S; Lindsell, Christopher J; Raab, Dana L; Ruffner, Andrew H; Trott, Alexander T; Fichtenbaum, Carl J (2009. ) Comparison of emergency department HIV testing data with visit or patient as the unit of analysis.Journal of medical screening, , 16 (1 ) ,29-32 More Information

Stein, James H; Komarow, Lauren; Cotter, Bruno R; Currier, Judith S; Dubé, Michael P; Fichtenbaum, Carl J; Gerschenson, Mariana; Mitchell, Carol K C; Murphy, Robert L; Squires, Kathleen; Parker, Robert A; Torriani, Francesca J (2008. ) Lipoprotein Changes in HIV-Infected Antiretroviral-Naïve Individuals after Starting Antiretroviral Therapy: ACTG Study A5152s Stein: Lipoprotein Changes on Antiretroviral Therapy.Journal of clinical lipidology, , 2 (6 ) ,464-471 More Information

Jacobson, Jeffrey M; Saag, Michael S; Thompson, Melanie A; Fischl, Margaret A; Liporace, Ralph; Reichman, Richard C; Redfield, Robert R; Fichtenbaum, Carl J; Zingman, Barry S; Patel, Mahesh C; Murga, Jose D; Pemrick, Suzanne M; D'Ambrosio, Paul; Michael, Marti; Kroger, Hans; Ly, Hieu; Rotshteyn, Yakov; Buice, Robert; Morris, Stephen A; Stavola, Joseph J; Maddon, Paul J; Kremer, Alton B; Olson, William C (2008. ) Antiviral activity of single-dose PRO 140, a CCR5 monoclonal antibody, in HIV-infected adults.The Journal of infectious diseases, , 198 (9 ) ,1345-52 More Information

Torriani, Francesca J; Komarow, Lauren; Parker, Robert A; Cotter, Bruno R; Currier, Judith S; Dubé, Michael P; Fichtenbaum, Carl J; Gerschenson, Mariana; Mitchell, Carol K C; Murphy, Robert L; Squires, Kathleen; Stein, James H (2008. ) Endothelial function in human immunodeficiency virus-infected antiretroviral-naive subjects before and after starting potent antiretroviral therapy: The ACTG (AIDS Clinical Trials Group) Study 5152s.Journal of the American College of Cardiology, , 52 (7 ) ,569-76 More Information

Dubé, Michael P; Lipshultz, Steven E; Fichtenbaum, Carl J; Greenberg, Richard; Schecter, Alison D; Fisher, Stacy D (2008. ) Effects of HIV infection and antiretroviral therapy on the heart and vasculature.Circulation, , 118 (2 ) ,e36-40 More Information

Vazquez, José A; Schranz, Jennifer A; Clark, Kay; Goldstein, Beth P; Reboli, Annette; Fichtenbaum, Carl (2008. ) A phase 2, open-label study of the safety and efficacy of intravenous anidulafungin as a treatment for azole-refractory mucosal candidiasis.Journal of acquired immune deficiency syndromes (1999), , 48 (3 ) ,304-9 More Information

Lyons, Michael S; Lindsell, Christopher J; R N, Deanna A Hawkins; Rn, Dana L Raab; Trott, Alexander T; Fichtenbaum, Carl J (2008. ) Contributions to early HIV diagnosis among patients linked to care vary by testing venue.BMC public health, , 8 ,220 More Information

Fichtenbaum, Carl J (2008. ) Editorial comment: the head bone is connected to the body bone. The AIDS reader, , 18 (5 ) ,265

Gerber, John G; Kitch, Douglas W; Fichtenbaum, Carl J; Zackin, Robert A; Charles, Stéphannie; Hogg, Evelyn; Acosta, Edward P; Connick, Elizabeth; Wohl, David; Kojic, E Milu; Benson, Constance A; Aberg, Judith A (2008. ) Fish oil and fenofibrate for the treatment of hypertriglyceridemia in HIV-infected subjects on antiretroviral therapy: results of ACTG A5186.Journal of acquired immune deficiency syndromes (1999), , 47 (4 ) ,459-66 More Information

Velilla, P A; Shata, M T; Lages, C S; Ying, J; Fichtenbaum, C J; Chougnet, C (2008. ) Effect of low-dose IL-2 immunotherapy on frequency and phenotype of regulatory T cells and NK cells in HIV/HCV-coinfected patients.AIDS research and human retroviruses, , 24 (1 ) ,52-61 More Information

Grandominico, Jodi M; Fichtenbaum, Carl J Short-term effect of HAART on blood pressure in HIV-infected individuals.HIV clinical trials, , 9 (1 ) ,52-60 More Information

de Perio, Marie A; Gomez, Francisco J; Frame, Peter T; Fichtenbaum, Carl J (2007. ) A truvada hypersensitivity reaction simulating abacavir hypersensitivity.AIDS (London, England), , 21 (16 ) ,2252-3 More Information

Lyons, Michael S; Raab, Dana L; Lindsell, Christopher J; Trott, Alexander T; Fichtenbaum, Carl J (2007. ) A novel emergency department based prevention intervention program for people living with HIV: evaluation of early experiences.BMC health services research, , 7 ,164 More Information

Lyons, Michael S; Lindsell, Christopher J; Fichtenbaum, Carl J; Camargo, Carlos A Interpreting and implementing the 2006 CDC recommendations for HIV testing in health-care settings. Public health reports (Washington, D.C. : 1974), , 122 (5 ) ,579-83

Shire, Norah J; Rouster, Susan D; Stanford, Sandra D; Blackard, Jason T; Martin, Christina M; Fichtenbaum, Carl J; Sherman, Kenneth E (2007. ) The prevalence and significance of occult hepatitis B virus in a prospective cohort of HIV-infected patients.Journal of acquired immune deficiency syndromes (1999), , 44 (3 ) ,309-14 More Information

Huang, I; Leach, J L; Fichtenbaum, C J; Narayan, R K (2007. ) Osteomyelitis of the skull in early-acquired syphilis: evaluation by MR imaging and CT. AJNR. American journal of neuroradiology, , 28 (2 ) ,307-8

Evans, Scott R; Fichtenbaum, Carl J; Aberg, Judith A Comparison of direct and indirect measurement of LDL-C in HIV-infected individuals: ACTG 5087.HIV clinical trials, , 8 (1 ) ,45-52 More Information

Wohl, D A; McComsey, G; Tebas, P; Brown, T T; Glesby, M J; Reeds, D; Shikuma, C; Mulligan, K; Dube, M; Wininger, D; Huang, J; Revuelta, M; Currier, J; Swindells, S; Fichtenbaum, C; Basar, M; Tungsiripat, M; Meyer, W; Weihe, J; Wanke, C (2006. ) Current concepts in the diagnosis and management of metabolic complications of HIV infection and its therapy.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , 43 (5 ) ,645-53 More Information

Robertson, Jaime; Meier, Matthew; Wall, Jennifer; Ying, Jun; Fichtenbaum, Carl J (2006. ) Immune reconstitution syndrome in HIV: validating a case definition and identifying clinical predictors in persons initiating antiretroviral therapy.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , 42 (11 ) ,1639-46 More Information

Aberg, Judith A; Rosenkranz, Susan L; Fichtenbaum, Carl J; Alston, Beverly L; Brobst, Susan W; Segal, Yoninah; Gerber, John G (2006. ) Pharmacokinetic interaction between nelfinavir and pravastatin in HIV-seronegative volunteers: ACTG Study A5108.AIDS (London, England), , 20 (5 ) ,725-9 More Information

Goldman, Mitchell; Cloud, Gretchen A; Wade, Karen D; Reboli, Annette C; Fichtenbaum, Carl J; Hafner, Richard; Sobel, Jack D; Powderly, William G; Patterson, Thomas F; Wheat, Lawrence J; Stein, David K; Dismukes, William E; Filler, Scott G (2005. ) A randomized study of the use of fluconazole in continuous versus episodic therapy in patients with advanced HIV infection and a history of oropharyngeal candidiasis: AIDS Clinical Trials Group Study 323/Mycoses Study Group Study 40.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , 41 (10 ) ,1473-80 More Information

Aberg, Judith A; Zackin, Robert A; Brobst, Susan W; Evans, Scott R; Alston, Beverly L; Henry, W Keith; Glesby, Marshall J; Torriani, Francesca J; Yang, Yijun; Owens, Susan I; Fichtenbaum, Carl J (2005. ) A randomized trial of the efficacy and safety of fenofibrate versus pravastatin in HIV-infected subjects with lipid abnormalities: AIDS Clinical Trials Group Study 5087.AIDS research and human retroviruses, , 21 (9 ) ,757-67 More Information

Glesby, Marshall J; Aberg, Judith A; Kendall, Michelle A; Fichtenbaum, Carl J; Hafner, Richard; Hall, Stephen; Grosskopf, Nicole; Zolopa, Andrew R; Gerber, John G (2005. ) Pharmacokinetic interactions between indinavir plus ritonavir and calcium channel blockers.Clinical pharmacology and therapeutics, , 78 (2 ) ,143-53 More Information

Gerber, John G; Rosenkranz, Susan L; Fichtenbaum, Carl J; Vega, Jose M; Yang, Amy; Alston, Beverly L; Brobst, Susan W; Segal, Yoninah; Aberg, Judith A (2005. ) Effect of efavirenz on the pharmacokinetics of simvastatin, atorvastatin, and pravastatin: results of AIDS Clinical Trials Group 5108 Study. Journal of acquired immune deficiency syndromes (1999), , 39 (3 ) ,307-12

Glesby, Marshall J; Bassett, Roland; Alston-Smith, Beverly; Fichtenbaum, Carl; Jacobson, Elizabeth L; Brass, Clifford; Owens, Susan; Sulkowski, Mark; Race, Elizabeth M; Sherman, Kenneth E (2005. ) Pilot study of low-dose interleukin-2, pegylated interferon-alpha 2b, and ribavirin for the treatment of hepatitis C virus infection in patients with HIV infection.The Journal of infectious diseases, , 191 (5 ) ,686-93 More Information

Fichtenbaum, Carl J; Hadigan, Colleen M; Kotler, Donald P; Pierone, Gerald; Sax, Paul E; Steinhart, Corklin R; Tebas, Pablo (2005. ) Treating morphologic and metabolic complications in HIV-infected patients on antiretroviral therapy. A consensus statement of an advisory committee of the International Association of Physicians in AIDS Care. IAPAC monthly, , 11 (2 ) ,38-46

Fichtenbaum, Carl J Coronary heart disease risk, dyslipidemia, and management in HIV-infected persons. HIV clinical trials, , 5 (6 ) ,416-33

Acosta, Edward P; Wu, Hulin; Hammer, Scott M; Yu, Song; Kuritzkes, Daniel R; Walawander, Ann; Eron, Joseph J; Fichtenbaum, Carl J; Pettinelli, Carla; Neath, Denise; Ferguson, Elaine; Saah, Alfred J; Gerber, John G (2004. ) Comparison of two indinavir/ritonavir regimens in the treatment of HIV-infected individuals. Journal of acquired immune deficiency syndromes (1999), , 37 (3 ) ,1358-66

Goldman, Mitchell; Zackin, Robert; Fichtenbaum, Carl J; Skiest, Daniel J; Koletar, Susan L; Hafner, Richard; Wheat, L Joseph; Nyangweso, Peter M; Yiannoutsos, Constantin T; Schnizlein-Bick, Carol T; Owens, Susan; Aberg, Judith A (2004. ) Safety of discontinuation of maintenance therapy for disseminated histoplasmosis after immunologic response to antiretroviral therapy.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , 38 (10 ) ,1485-9 More Information

Zhang, Rui; Fichtenbaum, Carl J; Hildeman, David A; Lifson, Jeffrey D; Chougnet, Claire (2004. ) CD40 ligand dysregulation in HIV infection: HIV glycoprotein 120 inhibits signaling cascades upstream of CD40 ligand transcription. Journal of immunology (Baltimore, Md. : 1950), , 172 (4 ) ,2678-86

Dubé, Michael P; Stein, James H; Aberg, Judith A; Fichtenbaum, Carl J; Gerber, John G; Tashima, Karen T; Henry, W Keith; Currier, Judith S; Sprecher, Dennis; Glesby, Marshall J (2003. ) Guidelines for the evaluation and management of dyslipidemia in human immunodeficiency virus (HIV)-infected adults receiving antiretroviral therapy: recommendations of the HIV Medical Association of the Infectious Disease Society of America and the Adult AIDS Clinical Trials Group.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , 37 (5 ) ,613-27 More Information

Riddle, Tara M; Fichtenbaum, Carl J; Hui, David Y (2003. ) Leptin replacement therapy but not dietary polyunsaturated fatty acid alleviates HIV protease inhibitor-induced dyslipidemia and lipodystrophy in mice. Journal of acquired immune deficiency syndromes (1999), , 33 (5 ) ,564-70

Fichtenbaum, Carl J (2003. ) Antiretrovirals and cardiovascular disease: is HAART bad for your heart? .AIDS clinical care, , 15 (8 ) ,69-73, 76

Landon, Bruce E; Wilson, Ira B; Cohn, Susan E; Fichtenbaum, Carl J; Wong, Mitchell D; Wenger, Neil S; Bozzette, Samuel A; Shapiro, Martin F; Cleary, Paul D (2003. ) Physician specialization and antiretroviral therapy for HIV. Journal of general internal medicine, , 18 (4 ) ,233-41

Levine, Nicholas B; Kurokawa, Ryu; Fichtenbaum, Carl J; Howington, John A; Kuntz, Charles (2002. ) An immunocompetent patient with primary Scedosporium apiospermum vertebral osteomyelitis. Journal of spinal disorders & techniques, , 15 (5 ) ,425-30

Daly, Kieran R; Fichtenbaum, Carl J; Tanaka, Reiko; Linke, Michael J; O'Bert, Robert; Thullen, Timothy D; Hui, Michele S; Smulian, Alan G; Walzer, Peter D (2002. ) Serologic responses to epitopes of the major surface glycoprotein of Pneumocystis jiroveci differ in human immunodeficiency virus-infected and uninfected persons.The Journal of infectious diseases, , 186 (5 ) ,644-51 More Information

Riddle, Tara M; Schildmeyer, Nicholas M; Phan, Cam; Fichtenbaum, Carl J; Hui, David Y (2002. ) The HIV protease inhibitor ritonavir increases lipoprotein production and has no effect on lipoprotein clearance in mice. Journal of lipid research, , 43 (9 ) ,1458-63

Fichtenbaum, Carl J; Gerber, John G; Rosenkranz, Susan L; Segal, Yoninah; Aberg, Judith A; Blaschke, Terrence; Alston, Beverly; Fang, Fang; Kosel, Bradley; Aweeka, Francesca (2002. ) Pharmacokinetic interactions between protease inhibitors and statins in HIV seronegative volunteers: ACTG Study A5047. AIDS (London, England), , 16 (4 ) ,569-77

David, Max H; Hornung, Richard; Fichtenbaum, Carl J (2002. ) Ischemic cardiovascular disease in persons with human immunodeficiency virus infection.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , 34 (1 ) ,98-102 More Information

Fichtenbaum, Carl J; Gerber, John G (2002. ) Interactions between antiretroviral drugs and drugs used for the therapy of the metabolic complications encountered during HIV infection. Clinical pharmacokinetics, , 41 (14 ) ,1195-211

Landon, Bruce E; Wilson, Ira B; Wenger, Neil S; Cohn, Susan E; Fichtenbaum, Carl J; Bozzette, Samuel A; Shapiro, Martin F; Cleary, Paul D (2002. ) Specialty training and specialization among physicians who treat HIV/AIDS in the United States. Journal of general internal medicine, , 17 (1 ) ,12-22

Fichtenbaum, C J (2001. ) The evaluation and management of dyslipidemia in HIV-infected patients. AIDS clinical care, , 13 (12 ) ,113-7, 120

Riddle, T M; Kuhel, D G; Woollett, L A; Fichtenbaum, C J; Hui, D Y (2001. ) HIV protease inhibitor induces fatty acid and sterol biosynthesis in liver and adipose tissues due to the accumulation of activated sterol regulatory element-binding proteins in the nucleus.The Journal of biological chemistry, , 276 (40 ) ,37514-9 More Information

Soloway, B; Fichtenbaum, C J (2001. ) One size does not fit all. AIDS clinical care, , 13 (10 ) ,92-3

Fichtenbaum, C J; Zackin, R; Feinberg, J (2001. ) Reply to 'Possible bias of ascertainment in assessing chemoprophylaxis for cryptosporidiosis' by Holmberg and Moorman. AIDS (London, England), , 15 (13 ) ,1745

Currier, J S; Williams, P; Feinberg, J; Becker, S; Owens, S; Fichtenbaum, C; Benson, C (2001. ) Impact of prophylaxis for Mycobacterium avium complex on bacterial infections in patients with advanced human immunodeficiency virus disease.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , 32 (11 ) ,1615-22 More Information

Tantisiriwat, W; Tebas, P; Polish, L B; Casabar, E; Powderly, W G; Fichtenbaum, C J (2001. ) Elevated lactate levels in hospitalized persons with HIV infection.AIDS research and human retroviruses, , 17 (3 ) ,195-201 More Information

Fichtenbaum, C J; Zackin, R; Feinberg, J; Benson, C; Griffiths, J K (2000. ) Rifabutin but not clarithromycin prevents cryptosporidiosis in persons with advanced HIV infection. AIDS (London, England), , 14 (18 ) ,2889-93

Taylor, B N; Fichtenbaum, C; Saavedra, M; Slavinsky III, J; Swoboda, R; Wozniak, K; Arribas, A; Powderly, W; Fidel Jr, P L (2000. ) In vivo virulence of Candida albicans isolates causing mucosal infections in people infected with the human immunodeficiency virus.The Journal of infectious diseases, , 182 (3 ) ,955-9 More Information

Fichtenbaum, C J; Zackin, R; Rajicic, N; Powderly, W G; Wheat, L J; Zingman, B S (2000. ) Amphotericin B oral suspension for fluconazole-refractory oral candidiasis in persons with HIV infection. Adult AIDS Clinical Trials Group Study Team 295. AIDS (London, England), , 14 (7 ) ,845-52

Fichtenbaum, C J; Koletar, S; Yiannoutsos, C; Holland, F; Pottage, J; Cohn, S E; Walawander, A; Frame, P; Feinberg, J; Saag, M; Van der Horst, C; Powderly, W G (2000. ) Refractory mucosal candidiasis in advanced human immunodeficiency virus infection.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , 30 (5 ) ,749-56 More Information

Fichtenbaum, C J; German, M; Dunagan, W C; Fraser, V J; Medoff, G; Diego, J; Powderly, W G (1999. ) A pilot study of the management of uncomplicated candidemia with a standardized protocol of amphotericin B.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , 29 (6 ) ,1551-6 More Information

Tantisiriwat, W; Tebas, P; Clifford, D B; Powderly, W G; Fichtenbaum, C J (1999. ) Progressive multifocal leukoencephalopathy in patients with AIDS receiving highly active antiretroviral therapy.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , 28 (5 ) ,1152-4 More Information

Widmer, G; Tzipori, S; Fichtenbaum, C J; Griffiths, J K (1998. ) Genotypic and phenotypic characterization of Cryptosporidium parvum isolates from people with AIDS. The Journal of infectious diseases, , 178 (3 ) ,834-40

Fichtenbaum, C J (1998. ) I hear you knockin' (but you can't come in): potent new HIV therapies are shutting out opportunistic infections. Research initiative, treatment action : RITA, , 4 (4 ) ,3-7

Cottler, L B; Compton, W M; Ben Abdallah, A; Cunningham-Williams, R; Abram, F; Fichtenbaum, C; Dotson, W (1998. ) Peer-delivered interventions reduce HIV risk behaviors among out-of-treatment drug abusers. Public health reports (Washington, D.C. : 1974), , 113 Suppl 1 ,31-41

Seydel, K B; Zhang, T; Champion, G A; Fichtenbaum, C; Swanson, P E; Tzipori, S; Griffiths, J K; Stanley, S L (1998. ) Cryptosporidium parvum infection of human intestinal xenografts in SCID mice induces production of human tumor necrosis factor alpha and interleukin-8. Infection and immunity, , 66 (5 ) ,2379-82

Fichtenbaum, C J; Powderly, W G (1998. ) Refractory mucosal candidiasis in patients with human immunodeficiency virus infection. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , 26 (3 ) ,556-65

Wu, A W; Jacobson, D L; Berzon, R A; Revicki, D A; van der Horst, C; Fichtenbaum, C J; Saag, M S; Lynn, L; Hardy, D; Feinberg, J (1997. ) The effect of mode of administration on medical outcomes study health ratings and EuroQol scores in AIDS. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation, , 6 (1 ) ,3-10

Fichtenbaum, C J; Clifford, D B; Powderly, W G (1995. ) Risk factors for dideoxynucleoside-induced toxic neuropathy in patients with the human immunodeficiency virus infection. Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association, , 10 (2 ) ,169-74

Arribas, J R; Clifford, D B; Fichtenbaum, C J; Commins, D L; Powderly, W G; Storch, G A (1995. ) Level of cytomegalovirus (CMV) DNA in cerebrospinal fluid of subjects with AIDS and CMV infection of the central nervous system. The Journal of infectious diseases, , 172 (2 ) ,527-31

Arribas, J R; Clifford, D B; Fichtenbaum, C J; Roberts, R L; Powderly, W G; Storch, G A (1995. ) Detection of Epstein-Barr virus DNA in cerebrospinal fluid for diagnosis of AIDS-related central nervous system lymphoma. Journal of clinical microbiology, , 33 (6 ) ,1580-3

Fichtenbaum, C J; Dunagan, W C; Powderly, W G (1995. ) Bacteremia in hospitalized patients infected with the human immunodeficiency virus: a case-control study of risk factors and outcome. Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association, , 8 (1 ) ,51-7

Fichtenbaum, C J; Woeltje, K F; Powderly, W G (1994. ) Serious Pseudomonas aeruginosa infections in patients infected with human immunodeficiency virus: a case-control study. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , 19 (3 ) ,417-22

Fichtenbaum, C J; Peterson, L R; Weil, G J (1993. ) Ehrlichiosis presenting as a life-threatening illness with features of the toxic shock syndrome. The American journal of medicine, , 95 (4 ) ,351-7

Fichtenbaum, C J; Ritchie, D J; Powderly, W G (1993. ) Use of paromomycin for treatment of cryptosporidiosis in patients with AIDS. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , 16 (2 ) ,298-300

Fichtenbaum, C J; Smith, M J (1992. ) Treatment of endocarditis due to Pseudomonas aeruginosa with imipenem. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , 14 (1 ) ,353-4

Afridi, S A; Fichtenbaum, C J; Taubin, H (1991. ) Review of duodenal diverticula. The American journal of gastroenterology, , 86 (8 ) ,935-8

Monteferrante, M L; Shimkin, P M; Fichtenbaum, C; Kleinman, G M; Lipow, K I Tentorial traversal by ependymoblastoma. AJNR. American journal of neuroradiology, , 12 (1 ) ,181

Fichtenbaum, C J; Kleinman, G M; Haddad, R G (1990. ) Eosinophilic granuloma of the lung presenting as a solitary pulmonary nodule. Thorax, , 45 (11 ) ,905-6

Fichtenbaum, C J; Babb, J D; Baker, D A (1988. ) Erythromycin induced cardiovascular toxicity. Connecticut medicine, , 52 (3 ) ,135-6

Samineni, Divya; Desai, Pankaj B; Sallans, Larry; Fichtenbaum, Carl J (2012. ) Steady-state pharmacokinetic interactions of darunavir/ritonavir with lipid-lowering agent rosuvastatin.Journal of clinical pharmacology, , 52 (6 ) ,922-31 More Information

Mohajer, Mayar Al; Lyons, Michael; King, Eileen; Pratt, Jesse; Fichtenbaum, Carl J Internal Medicine and Emergency Medicine Physicians Lack Accurate Knowledge of Current CDC HIV Testing Recommendations and Infrequently Offer HIV Testing.Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002), , 11 (2 ) ,101-8 More Information

Fichtenbaum, Carl J; Evans, Scott E; Aberg, Judith A (2011. ) High-sensitivity C-reactive protein levels do not decrease with the use of statins in all persons with HIV infection.AIDS (London, England), , 25 (16 ) ,2053 More Information

Nyakeriga, Alice M; Ying, Jun; Shire, Norah J; Fichtenbaum, Carl J; Chougnet, Claire A (2011. ) Highly active antiretroviral therapy in patients infected with human immunodeficiency virus increases CD40 ligand expression and IL-12 production in cells ex vivo.Viral immunology, , 24 (4 ) ,281-9 More Information

Lyons, Michael S; Lindsell, Christopher J; Wayne, D Beth; Ruffner, Andrew H; Hart, Kimberly W; Fichtenbaum, Carl J; Trott, Alexander T; Sullivan, Patrick S (2011. ) Comparison of missed opportunities for earlier HIV diagnosis in 3 geographically proximate emergency departments.Annals of emergency medicine, , 58 (1 Suppl 1 ) ,S17-22.e1 More Information

Hudepohl, Nathan J; Lindsell, Christopher J; Hart, Kimberly W; Ruffner, Andrew H; Trott, Alexander T; Fichtenbaum, Carl J; Lyons, Michael S (2011. ) Effect of an emergency department HIV testing program on the proportion of emergency department patients who have been tested.Annals of emergency medicine, , 58 (1 Suppl 1 ) ,S140-4 More Information

Sitlinger, Andrea P; Lindsell, Christopher J; Ruffner, Andrew H; Wayne, D Beth; Hart, Kimberly W; Trott, Alexander T; Fichtenbaum, Carl J; Lyons, Michael S (2011. ) Preliminary program evaluation of emergency department HIV prevention counseling.Annals of emergency medicine, , 58 (1 Suppl 1 ) ,S120-5.e1-3 More Information

Ubhayakar, Nitin D; Lindsell, Christopher J; Raab, Dana L; Ruffner, Andrew H; Trott, Alexander T; Fichtenbaum, Carl J; Lyons, Michael S (2011. ) Risk, reasons for refusal, and impact of counseling on consent among ED patients declining HIV screening.The American journal of emergency medicine, , 29 (4 ) ,367-72 More Information

Fichtenbaum, Carl J (2011. ) Inflammatory Markers Associated with Coronary Heart Disease in Persons with HIV Infection.Current infectious disease reports, , 13 (1 ) ,94-101 More Information

Presicce, Pietro; Orsborn, Kris; King, Eileen; Pratt, Jesse; Fichtenbaum, Carl J; Chougnet, Claire A (2011. ) Frequency of circulating regulatory T cells increases during chronic HIV infection and is largely controlled by highly active antiretroviral therapy.PloS one, , 6 (12 ) ,e28118 More Information

Fichtenbaum, Carl J; Yeh, Tzu-Min; Evans, Scott R; Aberg, Judith A Treatment with pravastatin and fenofibrate improves atherogenic lipid profiles but not inflammatory markers in ACTG 5087.Journal of clinical lipidology, , 4 (4 ) ,279-87 More Information

Riddle, T M; Kuhel, D G; Woollett, L A; Fichtenbaum, C J; Hui, D Y (2001. ) HIV protease inhibitor induces fatty acid and sterol biosynthesis in liver and adipose tissues due to the accumulation of activated sterol regulatory element-binding proteins in the nucleus.The Journal of biological chemistry, , 276 (40 ) ,37514-9 More Information

Wohl, David A; Arnoczy, Gretchen; Fichtenbaum, Carl J; Campbell, Thomas; Taiwo, Babafemi; Hicks, Charles; McComsey, Grace A; Koletar, Susan; Sax, Paul; Tebas, Pablo; Ha, Belinda; Massengale, Kelly; Walsh, Kendall; Stein, James H (2013. ) Comparison of cardiovascular disease risk markers in HIV-infected patients receiving abacavir and tenofovir: the nucleoside inflammation, coagulation and endothelial function (NICE) study.Antiviral therapy, , More Information

Lyons, Michael S; Lindsell, Christopher J; Ruffner, Andrew H; Wayne, D Beth; Hart, Kimberly W; Sperling, Matthew I; Trott, Alexander T; Fichtenbaum, Carl J (2013. ) Randomized Comparison of Universal and Targeted HIV Screening in the Emergency Department.Journal of acquired immune deficiency syndromes (1999), , More Information

McComsey, Grace A; Daar, Eric S; O'Riordan, MaryAnn; Collier, Ann C; Kosmiski, Lisa; Santana, Jorge L; Fichtenbaum, Carl J; Fink, Heidi; Sax, Paul E; Libutti, Daniel E; Gerschenson, Mariana (2013. ) Changes in fat mitochondrial DNA and function in subjects randomized to abacavir-lamivudine or tenofovir DF-emtricitabine with atazanavir-ritonavir or efavirenz: AIDS Clinical Trials Group study A5224s, substudy of A5202.The Journal of infectious diseases, , 207 (4 ) ,604-11 More Information

Presicce, Pietro; Moreno-Fernandez, Maria E; Rusie, Laura K; Fichtenbaum, Carl; Chougnet, Claire A (2012. ) In vitro HIV infection impairs the capacity of myeloid dendritic cells to induce regulatory T cells.PloS one, , 7 (8 ) ,e42802 More Information

Warm, Eric J; Mathis, Bradley R; Held, Justin D; Pai, Savita; Tolentino, Jonathan; Ashbrook, Lauren; Lee, Cheryl K; Lee, David; Wood, Sharice; Fichtenbaum, Carl J; Schauer, Daniel; Munyon, Ryan; Mueller, Caroline (2014. ) Entrustment and Mapping of Observable Practice Activities for Resident Assessment.Journal of general internal medicine, , More Information

Taiwo, Babafemi; Zheng, Lu; Gallien, Sebastien; Matining, Roy M; Kuritzkes, Daniel R; Wilson, Cara C; Berzins, Baiba I; Acosta, Edward P; Bastow, Barbara; Kim, Peter S; Eron, Joseph J (2011. ) Efficacy of a nucleoside-sparing regimen of darunavir/ritonavir plus raltegravir in treatment-naive HIV-1-infected patients (ACTG A5262).AIDS (London, England), , 25 (17 ) ,2113-22 More Information

Sax, Paul E; Tierney, Camlin; Collier, Ann C; Daar, Eric S; Mollan, Katie; Budhathoki, Chakra; Godfrey, Catherine; Jahed, Nasreen C; Myers, Laurie; Katzenstein, David; Farajallah, Awny; Rooney, James F; Ha, Belinda; Woodward, William C; Feinberg, Judith; Tashima, Karen; Murphy, Robert L; Fischl, Margaret A (2011. ) Abacavir/lamivudine versus tenofovir DF/emtricitabine as part of combination regimens for initial treatment of HIV: final results.The Journal of infectious diseases, , 204 (8 ) ,1191-201 More Information

Brehm, Jessica H; Lalama, Christina M; Hughes, Michael D; Haubrich, Richard; Riddler, Sharon A; Sluis-Cremer, Nicolas; Mellors, John W (2011. ) Failure of initial therapy with two nucleosides and efavirenz is not associated with early emergence of mutations in the C-terminus of HIV-1 reverse transcriptase.Journal of acquired immune deficiency syndromes (1999), , 56 (4 ) ,344-8 More Information

McComsey, Grace A; Walker, Ulrich A; Budhathoki, Chakra B; Su, Zhaohui; Currier, Judith S; Kosmiski, Lisa; Naini, Linda G; Charles, Stéphannie; Medvik, Kathy; Aberg, Judith A (2010. ) Uridine supplementation in the treatment of HIV lipoatrophy: results of ACTG 5229.AIDS (London, England), , 24 (16 ) ,2507-15 More Information

Flexner, Charles; Tierney, Camlin; Gross, Robert; Andrade, Adriana; Lalama, Christina; Eshleman, Susan H; Aberg, Judith; Sanne, Ian; Parsons, Teresa; Kashuba, Angela; Rosenkranz, Susan L; Kmack, Anne; Ferguson, Elaine; Dehlinger, Marjorie; Mildvan, Donna (2010. ) Comparison of once-daily versus twice-daily combination antiretroviral therapy in treatment-naive patients: results of AIDS clinical trials group (ACTG) A5073, a 48-week randomized controlled trial.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , 50 (7 ) ,1041-52 More Information

Gross, Robert; Tierney, Camlin; Andrade, Adriana; Lalama, Christina; Rosenkranz, Susan; Eshleman, Susan H; Flanigan, Timothy; Santana, Jorge; Salomon, Nadim; Reisler, Ronald; Wiggins, Ilene; Hogg, Evelyn; Flexner, Charles; Mildvan, Donna (2009. ) Modified directly observed antiretroviral therapy compared with self-administered therapy in treatment-naive HIV-1-infected patients: a randomized trial.Archives of internal medicine, , 169 (13 ) ,1224-32 More Information

Haubrich, Richard H; Riddler, Sharon A; DiRienzo, A Gregory; Komarow, Lauren; Powderly, William G; Klingman, Karin; Garren, Kevin W; Butcher, David L; Rooney, James F; Haas, David W; Mellors, John W; Havlir, Diane V (2009. ) Metabolic outcomes in a randomized trial of nucleoside, nonnucleoside and protease inhibitor-sparing regimens for initial HIV treatment.AIDS (London, England), , 23 (9 ) ,1109-18 More Information

Riddler, Sharon A; Haubrich, Richard; DiRienzo, A Gregory; Peeples, Lynne; Powderly, William G; Klingman, Karin L; Garren, Kevin W; George, Tania; Rooney, James F; Brizz, Barbara; Lalloo, Umesh G; Murphy, Robert L; Swindells, Susan; Havlir, Diane; Mellors, John W (2008. ) Class-sparing regimens for initial treatment of HIV-1 infection.The New England journal of medicine, , 358 (20 ) ,2095-106 More Information

Sandler, Netanya G; Zhang, Xinyan; Bosch, Ronald J; Funderburg, Nicholas T; Choi, Andrew I; Robinson, Janet K; Fine, Derek M; Coombs, Robert W; Jacobson, Jeffrey M; Landay, Alan L; Douek, Daniel C; Tressler, Randall; Read, Sarah W; Wilson, Cara C; Deeks, Steven G; Lederman, Michael M; Gandhi, Rajesh T (2014. ) Sevelamer does not decrease lipopolysaccharide or soluble CD14 levels but decreases soluble tissue factor, low-density lipoprotein (LDL) cholesterol, and oxidized LDL cholesterol levels in individuals with untreated HIV infection.The Journal of infectious diseases, , 210 (10 ) ,1549-54 More Information

Lennox, J L; Landovitz, R J; Ribaudo, H J; Ofotokun, I; Na, L H; Godfrey, C; Kuritzkes, D R; Sagar, M; Brown, T T; Cohn, S E; McComsey, G A; Aweeka, F; Fichtenbaum, C J; Presti, R M; Koletar, S L; Haas, D W; Patterson, K B; Benson, C A; Baugh, B P; Leavitt, R Y; Rooney, J F; Seekins, D; Currier, J S (2014. ) Summaries for patients. Nonnucleoside reverse transcriptase inhibitor-sparing antiretroviral regimens for treatment-naive volunteers infected with HIV-1.Annals of internal medicine, , 161 (7 ) ,I-22 More Information

Lennox, Jeffrey L; Landovitz, Raphael J; Ribaudo, Heather J; Ofotokun, Ighovwerha; Na, Lumine H; Godfrey, Catherine; Kuritzkes, Daniel R; Sagar, Manish; Brown, Todd T; Cohn, Susan E; McComsey, Grace A; Aweeka, Francesca; Fichtenbaum, Carl J; Presti, Rachel M; Koletar, Susan L; Haas, David W; Patterson, Kristine B; Benson, Constance A; Baugh, Bryan P; Leavitt, Randi Y; Rooney, James F; Seekins, Daniel; Currier, Judith S (2014. ) Efficacy and tolerability of 3 nonnucleoside reverse transcriptase inhibitor-sparing antiretroviral regimens for treatment-naive volunteers infected with HIV-1: a randomized, controlled equivalence trial.Annals of internal medicine, , 161 (7 ) ,461-71 More Information

Moschella, Phillip C; Hart, Kimberly W; Ruffner, Andrew H; Lindsell, Christopher J; Wayne, D Beth; Sperling, Matthew I; Trott, Alexander T; Fichtenbaum, Carl J; Lyons, Michael S (2014. ) Prevalence of undiagnosed acute and chronic HIV in a lower-prevalence urban emergency department.American journal of public health, , 104 (9 ) ,1695-9 More Information

Taiwo, Babafemi O; Chan, Ellen S; Fichtenbaum, Carl J; Ribaudo, Heather; Tsibris, Athe; Klingman, Karin L; Eron, Joseph J; Berzins, Baiba; Robertson, Kevin; Landay, Alan; Ofotokun, Igho; Brown, Todd (2015. ) Less Bone Loss With Maraviroc- Versus Tenofovir-Containing Antiretroviral Therapy in the AIDS Clinical Trials Group A5303 Study.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , 61 (7 ) ,1179-88 More Information

Dubé, Michael P; Komarow, Lauren; Fichtenbaum, Carl J; Cadden, Joseph J; Overton, Edgar T; Hodis, Howard N; Currier, Judith S; Stein, James H (2015. ) Extended-Release Niacin Versus Fenofibrate in HIV-Infected Participants With Low High-Density Lipoprotein Cholesterol: Effects on Endothelial Function, Lipoproteins, and Inflammation.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , 61 (5 ) ,840-9 More Information

Tashima, Karen T; Mollan, Katie R; Na, Lumine; Gandhi, Rajesh T; Klingman, Karin L; Fichtenbaum, Carl J; Andrade, Adriana; Johnson, Victoria A; Eron, Joseph J; Smeaton, Laura; Haubrich, Richard H (2015. ) Regimen selection in the OPTIONS trial of HIV salvage therapy: drug resistance, prior therapy, and race-ethnicity determine the degree of regimen complexity.HIV clinical trials, , 16 (4 ) ,147-56 More Information

Longenecker, Chris T; Kitch, Douglas; Sax, Paul E; Daar, Eric S; Tierney, Camlin; Gupta, Samir K; McComsey, Grace A (2015. ) Reductions in Plasma Cystatin C After Initiation of Antiretroviral Therapy Are Associated With Reductions in Inflammation: ACTG A5224s.Journal of acquired immune deficiency syndromes (1999), , 69 (2 ) ,168-77 More Information

Gianella, Sara; Marconi, Vincent C; Berzins, Baiba; Benson, Constance A; Sax, Paul; Fichtenbaum, Carl J; Wilkin, Timothy; Vargas, Millie; Deng, Qianqian; Oliveira, Michelli F; Moser, Carlee; Taiwo, Babafemi O (2018. ) Genital HIV-1 Shedding With Dolutegravir (DTG) Plus Lamivudine (3TC) Dual Therapy.Journal of acquired immune deficiency syndromes (1999), , 79 (5 ) ,e112-e114 More Information

Kalayjian, Robert C; Albert, Jeffrey M; Cremers, Serge; Gupta, Samir K; McComsey, Grace A; Klingman, Karin L; Fichtenbaum, Carl J; Brown, Todd T; Taiwo, Babafemi O (2018. ) Women have enhanced bone loss associated with phosphaturia and CD4+ cell restoration during initial antiretroviral therapy.AIDS (London, England), , 32 (17 ) ,2517-2524 More Information

Cahn, Pedro; Madero, Juan Sierra; Arribas, José Ramón; Antinori, Andrea; Ortiz, Roberto; Clarke, Amanda E; Hung, Chien-Ching; Rockstroh, Jürgen K; Girard, Pierre-Marie; Sievers, Jörg; Man, Choy; Currie, Alexander; Underwood, Mark; Tenorio, Allan R; Pappa, Keith; Wynne, Brian; Fettiplace, Anna; Gartland, Martin; Aboud, Michael; Smith, Kimberly (2018. ) Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials.Lancet (London, England), , More Information

Hsue, Priscilla Y; Ribaudo, Heather J; Deeks, Steven G; Bell, Tanvir; Ridker, Paul M; Fichtenbaum, Carl; Daar, Eric S; Havlir, Diane; Yeh, Eunice; Tawakol, Ahmed; Lederman, Michael; Currier, Judith S; Stein, James H (2018. ) Safety and Impact of Low-Dose Methotrexate on Endothelial Function and Inflammation in Individuals with Treated Human Immunodeficiency Virus: AIDS Clinical Trials Group Study A5314.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , More Information

Huaman, Moises A; Henson, David; Rondan, Paola L; Ticona, Eduardo; Miranda, Gustavo; Kryscio, Richard J; Mugruza, Raquel; Aranda, Ernesto; Ticona, Cesar; Abarca, Susan; Heredia, Paula; Aguirre, Andres; Sterling, Timothy R; Garvy, Beth A; Fichtenbaum, Carl J (2018. ) Latent tuberculosis infection is associated with increased unstimulated levels of interferon-gamma in Lima, Peru.PloS one, , 13 (9 ) ,e0202191 More Information

Rai, Mohammad A; Pannek, Sam; Fichtenbaum, Carl J (2018. ) Emerging reverse transcriptase inhibitors for HIV-1 infection.Expert opinion on emerging drugs, , 23 (2 ) ,149-157 More Information

Taiwo, Babafemi O; Marconi, Vincent C; Berzins, Baiba; Moser, Carlee B; Nyaku, Amesika N; Fichtenbaum, Carl J; Benson, Constance A; Wilkin, Timothy; Koletar, Susan L; Colasanti, Jonathan; Acosta, Edward P; Li, Jonathan Z; Sax, Paul E (2018. ) Dolutegravir Plus Lamivudine Maintains Human Immunodeficiency Virus-1 Suppression Through Week 48 in a Pilot Randomized Trial.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , 66 (11 ) ,1794-1797 More Information

Utay, Netanya S; Kitch, Douglas W; Yeh, Eunice; Fichtenbaum, Carl J; Lederman, Michael M; Estes, Jacob D; Deleage, Claire; Magyar, Clara; Nelson, Scott D; Klingman, Karen L; Bastow, Barbara; Luque, Amneris E; McComsey, Grace A; Douek, Daniel C; Currier, Judith S; Lake, Jordan E (2018. ) Telmisartan Therapy Does Not Improve Lymph Node or Adipose Tissue Fibrosis More Than Continued Antiretroviral Therapy Alone.The Journal of infectious diseases, , 217 (11 ) ,1770-1781 More Information

Huaman, Moises A; Ticona, Eduardo; Miranda, Gustavo; Kryscio, Richard J; Mugruza, Raquel; Aranda, Ernesto; Rondan, Paola L; Henson, David; Ticona, Cesar; Sterling, Timothy R; Fichtenbaum, Carl J; Garvy, Beth A (2018. ) The Relationship Between Latent Tuberculosis Infection and Acute Myocardial Infarction.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , 66 (6 ) ,886-892 More Information

Shive, Carey L; Judge, Chelsey J; Clagett, Brian; Kalayjian, Robert C; Osborn, Melissa; Sherman, Kenneth E; Fichtenbaum, Carl; Gandhi, Rajesh T; Kang, Minhee; Popkin, Daniel L; Sieg, Scott F; Lederman, Michael M; Rodriguez, Benigno; Anthony, Donald D (2018. ) Pre-vaccine plasma levels of soluble inflammatory indices negatively predict responses to HAV, HBV, and tetanus vaccines in HCV and HIV infection.Vaccine, , 36 (4 ) ,453-460 More Information

Perazzo, Joseph D; Webel, Allison R; Fichtenbaum, Carl J; McComsey, Grace A Bone Health in People Living With HIV: The Role of Exercise and Directions for Future Research.The Journal of the Association of Nurses in AIDS Care : JANAC, , 29 (2 ) ,330-337 More Information

Orkin, Chloe; Molina, Jean-Michel; Negredo, Eugenia; Arribas, José R; Gathe, Joseph; Eron, Joseph J; Van Landuyt, Erika; Lathouwers, Erkki; Hufkens, Veerle; Petrovic, Romana; Vanveggel, Simon; Opsomer, Magda (2018. ) Efficacy and safety of switching from boosted protease inhibitors plus emtricitabine and tenofovir disoproxil fumarate regimens to single-tablet darunavir, cobicistat, emtricitabine, and tenofovir alafenamide at 48 weeks in adults with virologically suppressed HIV-1 (EMERALD): a phase 3, randomised, non-inferiority trial.The lancet. HIV, , 5 (1 ) ,e23-e34 More Information

Rentz, Michael F; Ruffner, Andrew H; Ancona, Rachel M; Hart, Kimberly W; Kues, John R; Barczak, Christopher M; Lindsell, Christopher J; Fichtenbaum, Carl J; Lyons, Michael S (2017. ) Pilot Integration of HIV Screening and Healthcare Settings with Multi- Component Social Network and Partner Testing for HIV Detection.Current HIV research, , 15 (5 ) ,372-381 More Information

Asmuth, David M; Hinkle, John E; LaMarca, Anthony; Fichtenbaum, Carl J; Somsouk, Ma; Utay, Netanya S; Shaw, Audrey L; Petschow, Bryon W; Detzel, Christopher J; Weaver, Eric M Evaluation of oral serum-derived bovine immunoglobulins in HIV-infected patients with chronic idiopathic diarrhea.HIV clinical trials, , 18 (5-6 ) ,205-213 More Information

Cahn, Pedro; Kaplan, Richard; Sax, Paul E; Squires, Kathleen; Molina, Jean-Michel; Avihingsanon, Anchalee; Ratanasuwan, Winai; Rojas, Evelyn; Rassool, Mohammed; Bloch, Mark; Vandekerckhove, Linos; Ruane, Peter; Yazdanpanah, Yazdan; Katlama, Christine; Xu, Xia; Rodgers, Anthony; East, Lilly; Wenning, Larissa; Rawlins, Sandy; Homony, Brenda; Sklar, Peter; Nguyen, Bach-Yen; Leavitt, Randi; Teppler, Hedy (2017. ) Raltegravir 1200 mg once daily versus raltegravir 400 mg twice daily, with tenofovir disoproxil fumarate and emtricitabine, for previously untreated HIV-1 infection: a randomised, double-blind, parallel-group, phase 3, non-inferiority trial.The lancet. HIV, , 4 (11 ) ,e486-e494 More Information

Huaman, M A; Kryscio, R J; Fichtenbaum, C J; Henson, D; Salt, E; Sterling, T R; Garvy, B A (2017. ) Tuberculosis and risk of acute myocardial infarction: a propensity score-matched analysis.Epidemiology and infection, , 145 (7 ) ,1363-1367 More Information

Huaman, Moises A; Deepe, George S; Fichtenbaum, Carl J Elevated Circulating Concentrations of Interferon-Gamma in Latent Tuberculosis Infection.Pathogens & immunity, , 1 (2 ) ,291-303 More Information

Chan, Ellen S; Landay, Alan L; Brown, Todd T; Ribaudo, Heather J; Mirmonsef, Paria; Ofotokun, Igho; Weitzmann, M Neale; Martinson, Jeffrey; Klingman, Karin L; Eron, Joseph J; Fichtenbaum, Carl J; Plants, Jill; Taiwo, Babafemi O (2016. ) Differential CD4+ cell count increase and CD4+?: ?CD8+ ratio normalization with maraviroc compared with tenofovir.AIDS (London, England), , 30 (13 ) ,2091-7 More Information

Stellbrink, Hans-Jürgen; Le Fevre, Eric; Carr, Andrew; Saag, Michael S; Mukwaya, Geoffrey; Nozza, Silvia; Valluri, Srinivas Rao; Vourvahis, Manoli; Rinehart, Alex R; McFadyen, Lynn; Fichtenbaum, Carl; Clark, Andrew; Craig, Charles; Fang, Annie F; Heera, Jayvant (2016. ) Once-daily maraviroc versus tenofovir/emtricitabine each combined with darunavir/ritonavir for initial HIV-1 treatment.AIDS (London, England), , 30 (8 ) ,1229-38 More Information

Lyons, Michael S; Kunnathur, Vidhya A; Rouster, Susan D; Hart, Kimberly W; Sperling, Matthew I; Fichtenbaum, Carl J; Sherman, Kenneth E (2016. ) Prevalence of Diagnosed and Undiagnosed Hepatitis C in a Midwestern Urban Emergency Department.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , 62 (9 ) ,1066-71 More Information

Jacobson, Jeffrey M; Zheng, Lu; Wilson, Cara C; Tebas, Pablo; Matining, Roy M; Egan, Michael A; Eldridge, John; Landay, Alan L; Clifford, David B; Luetkemeyer, Anne F; Tiu, Jennifer; Martinez, Ana L; Janik, Jennifer; Spitz, Teresa A; Hural, John; McElrath, Juliana; Frahm, Nicole (2016. ) The Safety and Immunogenicity of an Interleukin-12-Enhanced Multiantigen DNA Vaccine Delivered by Electroporation for the Treatment of HIV-1 Infection.Journal of acquired immune deficiency syndromes (1999), , 71 (2 ) ,163-71 More Information

Tashima, Karen T; Smeaton, Laura M; Fichtenbaum, Carl J; Andrade, Adriana; Eron, Joseph J; Gandhi, Rajesh T; Johnson, Victoria A; Klingman, Karin L; Ritz, Justin; Hodder, Sally; Santana, Jorge L; Wilkin, Timothy; Haubrich, Richard H (2015. ) HIV Salvage Therapy Does Not Require Nucleoside Reverse Transcriptase Inhibitors: A Randomized, Controlled Trial.Annals of internal medicine, , 163 (12 ) ,908-17 More Information

El Sahly, Hana M; Baden, Lindsey R; Essink, Brandon; Doblecki-Lewis, Susanne; Martin, Judith M; Anderson, Evan J; Campbell, Thomas B; Clark, Jesse; Jackson, Lisa A; Fichtenbaum, Carl J; Zervos, Marcus; Rankin, Bruce; Eder, Frank; Feldman, Gregory; Kennelly, Christina; Han-Conrad, Laurie; Levin, Michael; Neuzil, Kathleen M; Corey, Lawrence; Gilbert, Peter; Janes, Holly; Follmann, Dean; Marovich, Mary; Polakowski, Laura; Mascola, John R; Ledgerwood, Julie E; Graham, Barney S; August, Allison; Clouting, Heather; Deng, Weiping; Han, Shu; Leav, Brett; Manzo, Deb; Pajon, Rolando; Schödel, Florian; Tomassini, Joanne E; Zhou, Honghong; Miller, Jacqueline (2021. ) Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase.The New England journal of medicine, , 385 (19 ) ,1774-1785 More Information

O'Brien, Meagan P; Forleo-Neto, Eduardo; Musser, Bret J; Isa, Flonza; Chan, Kuo-Chen; Sarkar, Neena; Bar, Katharine J; Barnabas, Ruanne V; Barouch, Dan H; Cohen, Myron S; Hurt, Christopher B; Burwen, Dale R; Marovich, Mary A; Hou, Peijie; Heirman, Ingeborg; Davis, John D; Turner, Kenneth C; Ramesh, Divya; Mahmood, Adnan; Hooper, Andrea T; Hamilton, Jennifer D; Kim, Yunji; Purcell, Lisa A; Baum, Alina; Kyratsous, Christos A; Krainson, James; Perez-Perez, Richard; Mohseni, Rizwana; Kowal, Bari; DiCioccio, A Thomas; Stahl, Neil; Lipsich, Leah; Braunstein, Ned; Herman, Gary; Yancopoulos, George D; Weinreich, David M (2021. ) Subcutaneous REGEN-COV Antibody Combination to Prevent Covid-19.The New England journal of medicine, , 385 (13 ) ,1184-1195 More Information

Landovitz, Raphael J; Donnell, Deborah; Clement, Meredith E; Hanscom, Brett; Cottle, Leslie; Coelho, Lara; Cabello, Robinson; Chariyalertsak, Suwat; Dunne, Eileen F; Frank, Ian; Gallardo-Cartagena, Jorge A; Gaur, Aditya H; Gonzales, Pedro; Tran, Ha V; Hinojosa, Juan C; Kallas, Esper G; Kelley, Colleen F; Losso, Marcelo H; Madruga, J Valdez; Middelkoop, Keren; Phanuphak, Nittaya; Santos, Breno; Sued, Omar; Valencia Huamaní, Javier; Overton, Edgar T; Swaminathan, Shobha; Del Rio, Carlos; Gulick, Roy M; Richardson, Paul; Sullivan, Philip; Piwowar-Manning, Estelle; Marzinke, Mark; Hendrix, Craig; Li, Maoji; Wang, Zhe; Marrazzo, Jeanne; Daar, Eric; Asmelash, Aida; Brown, Todd T; Anderson, Peter; Eshleman, Susan H; Bryan, Marcus; Blanchette, Cheryl; Lucas, Jonathan; Psaros, Christina; Safren, Steven; Sugarman, Jeremy; Scott, Hyman; Eron, Joseph J; Fields, Sheldon D; Sista, Nirupama D; Gomez-Feliciano, Kailazarid; Jennings, Andrea; Kofron, Ryan M; Holtz, Timothy H; Shin, Katherine; Rooney, James F; Smith, Kimberly Y; Spreen, William; Margolis, David; Rinehart, Alex; Adeyeye, Adeola; Cohen, Myron S; McCauley, Marybeth; Grinsztejn, Beatriz (2021. ) Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women.The New England journal of medicine, , 385 (7 ) ,595-608 More Information

Eckman, Mark H; Powers-Fletcher, Margaret V; Forrester, Jennifer W; Fichtenbaum, Carl J; Lofgren, Richard; Smulian, Alan George Take Your Best Shot: Which SARS-CoV-2 Vaccine Should I Get?.MDM policy & practice, , 6 (2 ) ,23814683211031226 More Information

Cohen, Myron S; Nirula, Ajay; Mulligan, Mark J; Novak, Richard M; Marovich, Mary; Yen, Catherine; Stemer, Alexander; Mayer, Stockton M; Wohl, David; Brengle, Blair; Montague, Brian T; Frank, Ian; McCulloh, Russell J; Fichtenbaum, Carl J; Lipson, Brad; Gabra, Nashwa; Ramirez, Julio A; Thai, Christine; Chege, Wairimu; Gomez Lorenzo, Margarita M; Sista, Nirupama; Farrior, Jennifer; Clement, Meredith E; Brown, Elizabeth R; Custer, Kenneth L; Van Naarden, Jacob; Adams, Andrew C; Schade, Andrew E; Dabora, Matan C; Knorr, Jack; Price, Karen L; Sabo, Janelle; Tuttle, Jay L; Klekotka, Paul; Shen, Lei; Skovronsky, Daniel M (2021. ) Effect of Bamlanivimab vs Placebo on Incidence of COVID-19 Among Residents and Staff of Skilled Nursing and Assisted Living Facilities: A Randomized Clinical Trial.JAMA, , 326 (1 ) ,46-55 More Information

Haukoos, Jason S; Lyons, Michael S; Rothman, Richard E; White, Douglas A E; Hopkins, Emily; Bucossi, Meggan; Ruffner, Andrew H; Ancona, Rachel M; Hsieh, Yu-Hsiang; Peterson, Stephen C; Signer, Danielle; Toerper, Matthew F; Saheed, Mustapha; Pfeil, Sarah K; Todorovic, Tamara; Al-Tayyib, Alia A; Bradley-Springer, Lucy; Campbell, Jonathan D; Gardner, Edward M; Rowan, Sarah E; Sabel, Allison L; Thrun, Mark W (2021. ) Comparison of HIV Screening Strategies in the Emergency Department: A Randomized Clinical Trial.JAMA network open, , 4 (7 ) ,e2117763 More Information

Zhang, Bin; Huaman, Moises A; Fichtenbaum, Carl J; Longenecker, Chris T (2021. ) Reply to Chu, et al.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , More Information

Douglas, Pamela S; Umbleja, Triin; Bloomfield, Gerald S; Fichtenbaum, Carl J; Zanni, Markella V; Overton, Edgar T; Fitch, Kathleen V; Kileel, Emma M; Aberg, Judith A; Currier, Judith; Sponseller, Craig A; Melbourne, Kathleen; Avihingsanon, Anchalee; Bustorff, Flavio; Estrada, Vicente; Ruxrungtham, Kiat; Saumoy, Maria; Navar, Ann Marie; Hoffmann, Udo; Ribaudo, Heather J; Grinspoon, Steven (2021. ) Cardiovascular Risk and Health Among People With HIV Eligible for Primary Prevention: Insights From the REPRIEVE Trial.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , More Information

Hoffmann, Udo; Lu, Michael T; Foldyna, Borek; Zanni, Markella V; Karady, Julia; Taron, Jana; Zhai, Bingxue K; Burdo, Tricia; Fitch, Kathleen V; Kileel, Emma M; Williams, Kenneth; Fichtenbaum, Carl J; Overton, Edgar T; Malvestutto, Carlos; Aberg, Judith; Currier, Judith; Sponseller, Craig A; Melbourne, Kathleen; Floris-Moore, Michelle; Van Dam, Cornelius; Keefer, Michael C; Koletar, Susan L; Douglas, Pamela S; Ribaudo, Heather; Mayrhofer, Thomas; Grinspoon, Steven K (2021. ) Assessment of Coronary Artery Disease With Computed Tomography Angiography and Inflammatory and Immune Activation Biomarkers Among Adults With HIV Eligible for Primary Cardiovascular Prevention.JAMA network open, , 4 (6 ) ,e2114923 More Information

Huaman, Moises A; Fichtenbaum, Carl J (2021. ) Bearing the Burden of Non-AIDS Comorbidities: This Is What Women Aging With Human Immunodefiency Virus Look Like.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , 72 (8 ) ,1312-1313 More Information

Huaman, Moises A; Juchnowski, Steven M; Zidar, David A; Kityo, Cissy M; Nalukwago, Sophie; Nazzinda, Rashidah; Fichtenbaum, Carl J; Longenecker, Chris T (2021. ) Monocyte activation in persons living with HIV and tuberculosis coinfection.AIDS (London, England), , 35 (3 ) ,447-452 More Information

Baden, Lindsey R; El Sahly, Hana M; Essink, Brandon; Kotloff, Karen; Frey, Sharon; Novak, Rick; Diemert, David; Spector, Stephen A; Rouphael, Nadine; Creech, C Buddy; McGettigan, John; Khetan, Shishir; Segall, Nathan; Solis, Joel; Brosz, Adam; Fierro, Carlos; Schwartz, Howard; Neuzil, Kathleen; Corey, Larry; Gilbert, Peter; Janes, Holly; Follmann, Dean; Marovich, Mary; Mascola, John; Polakowski, Laura; Ledgerwood, Julie; Graham, Barney S; Bennett, Hamilton; Pajon, Rolando; Knightly, Conor; Leav, Brett; Deng, Weiping; Zhou, Honghong; Han, Shu; Ivarsson, Melanie; Miller, Jacqueline; Zaks, Tal (2021. ) Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.The New England journal of medicine, , 384 (5 ) ,403-416 More Information

Fichtenbaum, Carl J; Ribaudo, Heather J; Leon-Cruz, Jorge; Overton, Edgar T; Zanni, Markella V; Malvestutto, Carlos D; Aberg, Judith A; Kileel, Emma M; Fitch, Kathleen V; Van Schalkwyk, Marije; Kumarasamy, Nagalingeswaran; Martinez, Esteban; Santos, Breno Riegel; Joseph, Yvetot; Lo, Janet; Siminski, Sue; Melbourne, Kathleen; Sponseller, Craig A; Desvigne-Nickens, Patrice; Bloomfield, Gerald S; Currier, Judith S; Hoffmann, Udo; Douglas, Pamela S; Grinspoon, Steven K (2021. ) Corrigendum to: Patterns of Antiretroviral Therapy Use and Immunologic Profiles at Enrollment in the REPRIEVE Trial.The Journal of infectious diseases, , 223 (2 ) ,352 More Information

Huaman, Moises A; De Cecco, Carlo N; Bittencourt, Marcio S; Ticona, Eduardo; Kityo, Cissy; Ballena, Isabel; Nalukwago, Sophie; Nazzinda, Rashidah; Ticona, Cesar; Azañero, Ruben; Zhang, Bin; Farquhar, Carey; Hawn, Thomas R; Sterling, Timothy R; Fichtenbaum, Carl J; Longenecker, Chris T (2021. ) Latent Tuberculosis Infection and Subclinical Coronary Atherosclerosis in Peru and Uganda.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , More Information

Huaman, Moises A; Qualls, Joseph E; Jose, Shinsmon; Schmidt, Stephanie M; Moussa, Anissa; Kuhel, David G; Konaniah, Eddy; Komaravolu, Ravi K; Fichtenbaum, Carl J; Deepe, George S; Hui, David Y (2020. ) Mycobacterium bovis Bacille-Calmette-Guérin Infection Aggravates Atherosclerosis.Frontiers in immunology, , 11 ,607957 More Information

Tassiopoulos, Katherine; Roberts-Toler, Carla; Fichtenbaum, Carl J; Koletar, Susan L (2020. ) Web-Based Data Collection for Older Adults Living With HIV in a Clinical Research Setting: Pilot Observational Study.Journal of medical Internet research, , 22 (11 ) ,e18588 More Information

Fichtenbaum, Carl J; Ribaudo, Heather J; Leon-Cruz, Jorge; Overton, Edgar T; Zanni, Markella V; Malvestutto, Carlos D; Aberg, Judith A; Kileel, Emma M; Fitch, Kathleen V; Van Schalkwyk, Marije; Kumarasamy, Nagalingeswaran; Martinez, Esteban; Santos, Breno Riegel; Joseph, Yvetot; Lo, Janet; Siminski, Sue; Melbourne, Kathleen; Sponseller, Craig A; Desvigne-Nickens, Patrice; Bloomfield, Gerald S; Currier, Judith S; Hoffmann, Udo; Douglas, Pamela S; Grinspoon, Steven K (2020. ) Patterns of Antiretroviral Therapy Use and Immunologic Profiles at Enrollment in the REPRIEVE Trial.The Journal of infectious diseases, , 222 (Suppl 1 ) ,S8-S19 More Information

Smith, Matthew S; Bonomo, Jordan; Knight, William A; Prestigiacomo, Charles J; Richards, Christopher T; Ramser, Evan; Adeoye, Opeolu; Bertsch, Stuart; Shirani, Peyman; Vagal, Achala; Fichtenbaum, Carl J; Housholder, Anne; Khatri, Pooja; Kleindorfer, Dawn O; Broderick, Joseph P; Grossman, Aaron W (2020. ) Endovascular Therapy for Patients With Acute Ischemic Stroke During the COVID-19 Pandemic: A Proposed Algorithm.Stroke, , 51 (6 ) ,1902-1909 More Information

Boccara, Franck; Kumar, Princy N; Caramelli, Bruno; Calmy, Alexandra; López, J Antonio G; Bray, Sarah; Cyrille, Marcoli; Rosenson, Robert S (2020. ) Evolocumab in HIV-Infected Patients With Dyslipidemia: Primary Results of the Randomized, Double-Blind BEIJERINCK Study.Journal of the American College of Cardiology, , 75 (20 ) ,2570-2584 More Information

Gandhi, Rajesh T; Tashima, Karen T; Smeaton, Laura M; Vu, Vincent; Ritz, Justin; Andrade, Adriana; Eron, Joseph J; Hogg, Evelyn; Fichtenbaum, Carl J (2020. ) Long-term Outcomes in a Large Randomized Trial of HIV-1 Salvage Therapy: 96-Week Results of AIDS Clinical Trials Group A5241 (OPTIONS).The Journal of infectious diseases, , 221 (9 ) ,1407-1415 More Information

Kozal, Michael; Aberg, Judith; Pialoux, Gilles; Cahn, Pedro; Thompson, Melanie; Molina, Jean-Michel; Grinsztejn, Beatriz; Diaz, Ricardo; Castagna, Antonella; Kumar, Princy; Latiff, Gulam; DeJesus, Edwin; Gummel, Mark; Gartland, Margaret; Pierce, Amy; Ackerman, Peter; Llamoso, Cyril; Lataillade, Max (2020. ) Fostemsavir in Adults with Multidrug-Resistant HIV-1 Infection.The New England journal of medicine, , 382 (13 ) ,1232-1243 More Information

Fitch, Kathleen V; Kileel, Emma M; Looby, Sara E; Zanni, Markella V; Sanchez, Laura R; Fichtenbaum, Carl J; Overton, Edgar T; Malvestutto, Carlos; Aberg, Judith A; Klingman, Karin L; Alston-Smith, Beverly; Lavelle, Judith; Rancourt, Anne; Badal-Faesen, Sharlaa; Cardoso, Sandra Wagner; Avihingsanon, Anchalee; Patil, Sandesh; Sponseller, Craig A; Melbourne, Kathleen; Ribaudo, Heather J; Cooper-Arnold, Katharine; Desvigne-Nickens, Patrice; Hoffmann, Udo; Douglas, Pamela S; Grinspoon, Steven K (2020. ) Successful recruitment of a multi-site international randomized placebo-controlled trial in people with HIV with attention to diversity of race and ethnicity: critical role of central coordination.HIV research & clinical practice, , 21 (1 ) ,11-23 More Information

Lathouwers, Erkki; Wong, Eric Y; Brown, Kimberley; Baugh, Bryan; Ghys, Anne; Jezorwski, John; Mohsine, El Ghazi; Van Landuyt, Erika; Opsomer, Magda; De Meyer, Sandra (2020. ) Week 48 Resistance Analyses of the Once-Daily, Single-Tablet Regimen Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) in Adults Living with HIV-1 from the Phase III Randomized AMBER and EMERALD Trials.AIDS research and human retroviruses, , 36 (1 ) ,48-57 More Information

Beigel, John H; Aga, Evgenia; Elie-Turenne, Marie-Carmelle; Cho, Josalyn; Tebas, Pablo; Clark, Carol L; Metcalf, Jordan P; Ozment, Caroline; Raviprakash, Kanakatte; Beeler, Joy; Holley, H Preston; Warner, Stephanie; Chorley, Carla; Lane, H Clifford; Hughes, Michael D; Davey, Richard T (2019. ) Anti-influenza immune plasma for the treatment of patients with severe influenza A: a randomised, double-blind, phase 3 trial.The Lancet. Respiratory medicine, , 7 (11 ) ,941-950 More Information

Eron, Joseph J; Orkin, Chloe; Cunningham, Douglas; Pulido, Federico; Post, Frank A; De Wit, Stéphane; Lathouwers, Erkki; Hufkens, Veerle; Jezorwski, John; Petrovic, Romana; Brown, Kimberley; Van Landuyt, Erika; Opsomer, Magda (2019. ) Week 96 efficacy and safety results of the phase 3, randomized EMERALD trial to evaluate switching from boosted-protease inhibitors plus emtricitabine/tenofovir disoproxil fumarate regimens to the once daily, single-tablet regimen of darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) in treatment-experienced, virologically-suppressed adults living with HIV-1.Antiviral research, , 170 ,104543 More Information

Gebhardt, Anna; Fichtenbaum, Carl J (2019. ) Current pharmacotherapy for the treatment of dyslipidemia associated with HIV infection.Expert opinion on pharmacotherapy, , 20 (14 ) ,1719-1729 More Information

Grinspoon, Steven K; Fitch, Kathleen V; Overton, Edgar Turner; Fichtenbaum, Carl J; Zanni, Markella V; Aberg, Judith A; Malvestutto, Carlos; Lu, Michael T; Currier, Judith S; Sponseller, Craig A; Waclawiw, Myron; Alston-Smith, Beverly; Cooper-Arnold, Katharine; Klingman, Karin L; Desvigne-Nickens, Patrice; Hoffmann, Udo; Ribaudo, Heather J; Douglas, Pamela S (2019. ) Rationale and design of the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE).American heart journal, , 212 ,23-35 More Information

Hoffmann, Udo; Lu, Michael T; Olalere, Devvora; Adami, Elizabeth C; Osborne, Michael T; Ivanov, Alex; Aluru, John Sukumar; Lee, Saeyun; Arifovic, Nadja; Overton, Edgar Turner; Fichtenbaum, Carl J; Aberg, Judith A; Alston-Smith, Beverly; Klingman, Karin L; Waclawiw, Myron; Burdo, Tricia H; Williams, Kenneth C; Zanni, Markella V; Desvigne-Nickens, Patrice; Cooper-Arnold, Katharine; Fitch, Kathleen V; Ribaudo, Heather; Douglas, Pamela S; Grinspoon, Steven K (2019. ) Rationale and design of the Mechanistic Substudy of the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE): Effects of pitavastatin on coronary artery disease and inflammatory biomarkers.American heart journal, , 212 ,1-12 More Information

Kalayjian, Robert C; Robertson, Kevin R; Albert, Jeffrey M; Fichtenbaum, Carl J; Brown, Todd T; Taiwo, Babafemi O (2019. ) Plasma Cystatin C Associates With HIV-Associated Neurocognitive Disorder but Is a Poor Diagnostic Marker in Antiretroviral Therapy-Treated Individuals.Journal of acquired immune deficiency syndromes (1999), , 81 (2 ) ,e49-e54 More Information

Utay, Netanya S; Somasunderam, Anoma; Hinkle, John E; Petschow, Bryon W; Detzel, Christopher J; Somsouk, Ma; Fichtenbaum, Carl J; Weaver, Eric M; Shaw, Audrey L; Asmuth, David M (2019. ) Serum Bovine Immunoglobulins Improve Inflammation and Gut Barrier Function in Persons with HIV and Enteropathy on Suppressive ART.Pathogens & immunity, , 4 (1 ) ,124-146 More Information

Li, Jonathan Z; Sax, Paul E; Marconi, Vincent C; Fajnzylber, Jesse; Berzins, Baiba; Nyaku, Amesika N; Fichtenbaum, Carl J; Wilkin, Timothy; Benson, Constance A; Koletar, Susan L; Lorenzo-Redondo, Ramon; Taiwo, Babafemi O (2019. ) No Significant Changes to Residual Viremia After Switch to Dolutegravir and Lamivudine in a Randomized Trial.Open forum infectious diseases, , 6 (3 ) ,ofz056 More Information

Bhattacharya, Romit; Uddin, Md Mesbah; Patel, Aniruddh P; Niroula, Abhishek; Finneran, Phoebe; Bernardo, Rachel; Fitch, Kathleen V; Lu, Michael T; Bloomfield, Gerald S; Malvestutto, Carlos; Aberg, Judy A; Fichtenbaum, Carl J; Hornsby, Whitney; Ribaudo, Heather J; Libby, Peter; Ebert, Benjamin L; Zanni, Markella V; Douglas, Pamela S; Grinspoon, Steven K; Natarajan, Pradeep (2024. ) Risk factors for clonal hematopoiesis of indeterminate potential in people with HIV: a report from the REPRIEVE trial.Blood advances, , 8 (4 ) ,959-967 More Information

Lu, Michael T; Ribaudo, Heather; Foldyna, Borek; Zanni, Markella V; Mayrhofer, Thomas; Karady, Julia; Taron, Jana; Fitch, Kathleen V; McCallum, Sara; Burdo, Tricia H; Paradis, Kayla; Hedgire, Sandeep S; Meyersohn, Nandini M; DeFilippi, Christopher; Malvestutto, Carlos D; Sturniolo, Audra; Diggs, Marissa; Siminski, Sue; Bloomfield, Gerald S; Alston-Smith, Beverly; Desvigne-Nickens, Patrice; Overton, Edgar T; Currier, Judith S; Aberg, Judith A; Fichtenbaum, Carl J; Hoffmann, Udo; Douglas, Pamela S; Grinspoon, Steven K (2024. ) Effects of Pitavastatin on Coronary Artery Disease and Inflammatory Biomarkers in HIV: Mechanistic Substudy of the REPRIEVE Randomized Clinical Trial.JAMA cardiology, , More Information

Orkin, Chloe; Molina, Jean-Michel; Cahn, Pedro; Lombaard, Johannes; Supparatpinyo, Khuanchai; Kumar, Sushma; Campbell, Havilland; Wan, Hong; Teal, Valerie; Jin Xu, Zhi; Asante-Appiah, Ernest; Sklar, Peter; Teppler, Hedy; Lahoulou, Rima (2024. ) Safety and efficacy of doravirine as first-line therapy in adults with HIV-1: week 192 results from the open-label extensions of the DRIVE-FORWARD and DRIVE-AHEAD phase 3 trials.The lancet. HIV, , 11 (2 ) ,e75-e85 More Information

Abidi, Maheen Z; Umbleja, Triin; Overton, Edgar T; Burdo, Tricia; Flynn, Jacqueline M; Lu, Michael T; Taron, Jana; Schnittman, Samuel R; Fitch, Kathleen V; Zanni, Markella V; Fichtenbaum, Carl J; Malvestutto, Carlos; Aberg, Judith A; Fulda, Evelynne S; Eckard, Allison Ross; Manne-Goehler, Jennifer; Tuan, Jessica J; Ribaudo, Heather J; Douglas, Pamela S; Grinspoon, Steven K; Brown, Todd T; Erlandson, Kristine M (2024. ) CMV IgG is Associated with Physical Function but not Muscle Density in People with HIV.Journal of acquired immune deficiency syndromes (1999), , More Information

Foldyna, Borek; Mayrhofer, Thomas; Zanni, Markella V; Lyass, Asya; Barve, Radhika; Karady, Julia; McCallum, Sara; Burdo, Tricia H; Fitch, Kathleen V; Paradis, Kayla; Fulda, Evelynne S; Diggs, Marissa R; Bloomfield, Gerald S; Malvestutto, Carlos D; Fichtenbaum, Carl J; Aberg, Judith A; Currier, Judith S; Ribaudo, Heather J; Hoffmann, Udo; Lu, Michael T; Douglas, Pamela S; Grinspoon, Steven K (2023. ) Pericoronary Adipose Tissue Density, Inflammation, and Subclinical Coronary Artery Disease Among People With HIV in the REPRIEVE Cohort.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , 77 (12 ) ,1676-1686 More Information

Lake, Jordan E; Taron, Jana; Ribaudo, Heather J; Leon-Cruz, Jorge; Utay, Netanya S; Swaminathan, Shobha; Fitch, Kathleen V; Kileel, Emma M; Paradis, Kayla; Fulda, Evelynne S; Ho, Ken S; Luetkemeyer, Anne F; Johnston, Carrie D; Zanni, Markella V; Douglas, Pamela S; Grinspoon, Steven K; Lu, Michael T; Fichtenbaum, Carl J (2023. ) Hepatic steatosis and nonalcoholic fatty liver disease are common and associated with cardiometabolic risk in a primary prevention cohort of people with HIV.AIDS (London, England), , 37 (14 ) ,2149-2159 More Information

Marzinke, Mark A; Hanscom, Brett; Wang, Zhe; Safren, Steven A; Psaros, Christina; Donnell, Deborah; Richardson, Paul A; Sullivan, Philip; Eshleman, Susan H; Jennings, Andrea; Feliciano, Kailazarid Gomez; Jalil, Emilia; Coutinho, Carolina; Cardozo, Nadir; Maia, Bernardo; Khan, Taimur; Singh, Yashna; Middelkoop, Keren; Franks, Julie; Valencia, Javier; Sanchez, Naiymah; Lucas, Jonathan; Rooney, James F; Rinehart, Alex R; Ford, Susan; Adeyeye, Adeola; Cohen, Myron S; McCauley, Marybeth; Landovitz, Raphael J; Grinsztejn, Beatriz (2023. ) Efficacy, safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir for HIV pre-exposure prophylaxis in transgender women: a secondary analysis of the HPTN 083 trial.The lancet. HIV, , 10 (11 ) ,e703-e712 More Information

Schnittman, Samuel R; Kolossváry, Márton; Beck-Engeser, Gabriele; Fitch, Kathleen V; Ambayec, Gabrielle C; Nance, Robin M; Zanni, Markella V; Diggs, Marissa; Chan, Fay; McCallum, Sara; Toribio, Mabel; Bamford, Laura; Fichtenbaum, Carl J; Eron, Joseph J; Jacobson, Jeffrey M; Mayer, Kenneth H; Malvestutto, Carlos; Bloomfield, Gerald S; Moore, Richard D; Umbleja, Triin; Saag, Michael S; Aberg, Judith A; Currier, Judith S; Delaney, Joseph A C; Martin, Jeffrey N; Lu, Michael T; Douglas, Pamela S; Ribaudo, Heather J; Crane, Heidi M; Hunt, Peter W; Grinspoon, Steven K (2023. ) Biological and Clinical Implications of the Vascular Endothelial Growth Factor Coreceptor Neuropilin-1 in Human Immunodeficiency Virus.Open forum infectious diseases, , 10 (10 ) ,ofad467 More Information

Rick, Anne-Marie; Laurens, Matthew B; Huang, Ying; Yu, Chenchen; Martin, Thomas C S; Rodriguez, Carina A; Rostad, Christina A; Maboa, Rebone M; Baden, Lindsey R; El Sahly, Hana M; Grinsztejn, Beatriz; Gray, Glenda E; Gay, Cynthia L; Gilbert, Peter B; Janes, Holly E; Kublin, James G; Huang, Yunda; Leav, Brett; Hirsch, Ian; Struyf, Frank; Dunkle, Lisa M; Neuzil, Kathleen M; Corey, Lawrence; Goepfert, Paul A; Walsh, Stephen R; Follmann, Dean; Kotloff, Karen L (2023. ) Risk of COVID-19 after natural infection or vaccination.EBioMedicine, , 96 ,104799 More Information

Erlandson, Kristine M; Umbleja, Triin; Lu, Michael T; Taron, Jana; Ribaudo, Heather J; Overton, Edgar T; Presti, Rachel M; Haas, David W; Sax, Paul E; Yin, Michael T; Zhai, Bingxue Kris; Louis, Rochelle; Upadhyay, Namrata; Eslami, Parastou; Douglas, Pamela S; Zanni, Markella V; Fitch, Kathleen V; Fulda, Evelynne S; Fichtenbaum, Carl J; Malvestutto, Carlos D; Grinspoon, Steven K; Brown, Todd T (2023. ) Associations of Muscle Density and Area With Coronary Artery Plaque and Physical Function.Journal of acquired immune deficiency syndromes (1999), , 94 (2 ) ,174-184 More Information

Haworth, Kevin J; Niederhausen, Kelly C; Smith, Eric P; Sadayappan, Sakthivel; Wess, Yolanda; Rubinstein, Jack; Schauer, Daniel P; Soleimani, Manoocher; Rouan, Gregory W; Fichtenbaum, Carl J (2023. ) Research Initiative Supporting Excellence at the University of Cincinnati (RISE-UC): A Program to Develop and Support Research-Active Faculty Members.Academic medicine : journal of the Association of American Medical Colleges, , 98 (10 ) ,1120-1130 More Information

Grinspoon, Steven K; Fitch, Kathleen V; Zanni, Markella V; Fichtenbaum, Carl J; Umbleja, Triin; Aberg, Judith A; Overton, Edgar T; Malvestutto, Carlos D; Bloomfield, Gerald S; Currier, Judith S; Martinez, Esteban; Roa, Jhoanna C; Diggs, Marissa R; Fulda, Evelynne S; Paradis, Kayla; Wiviott, Stephen D; Foldyna, Borek; Looby, Sara E; Desvigne-Nickens, Patrice; Alston-Smith, Beverly; Leon-Cruz, Jorge; McCallum, Sara; Hoffmann, Udo; Lu, Michael T; Ribaudo, Heather J; Douglas, Pamela S (2023. ) Pitavastatin to Prevent Cardiovascular Disease in HIV Infection.The New England journal of medicine, , 389 (8 ) ,687-699 More Information

Theodore, Deborah A; Branche, Angela R; Zhang, Lily; Graciaa, Daniel S; Choudhary, Madhu; Hatlen, Timothy J; Osman, Raadhiya; Babu, Tara M; Robinson, Samuel T; Gilbert, Peter B; Follmann, Dean; Janes, Holly; Kublin, James G; Baden, Lindsey R; Goepfert, Paul; Gray, Glenda E; Grinsztejn, Beatriz; Kotloff, Karen L; Gay, Cynthia L; Leav, Brett; Miller, Jacqueline; Hirsch, Ian; Sadoff, Jerald; Dunkle, Lisa M; Neuzil, Kathleen M; Corey, Lawrence; Falsey, Ann R; El Sahly, Hana M; Sobieszczyk, Magdalena E; Huang, Yunda (2023. ) Clinical and Demographic Factors Associated With COVID-19, Severe COVID-19, and SARS-CoV-2 Infection in Adults: A Secondary Cross-Protocol Analysis of 4 Randomized Clinical Trials.JAMA network open, , 6 (7 ) ,e2323349 More Information

Kileel, Emma M; Malvestutto, Carlos D; Lo, Janet; Fitch, Kathleen V; Fichtenbaum, Carl J; Aberg, Judith A; Zanni, Markella V; Martinez, Esteban; Okeke, Nwora Lance; Kumar, Princy; Joao, Esau; Bares, Sara H; Berrner, Daniel; Smieja, Marek; Roa, Jhoanna C; McCallum, Sara; Douglas, Pamela S; Ribaudo, Heather J; Grinspoon, Steven K (2023. ) Changes in Body Mass Index with Longer-term Integrase Inhibitor Use: A Longitudinal Analysis of Data from the Randomized Trial to Prevent Vascular Events in Human Immunodeficiency Virus (REPRIEVE).Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , 76 (11 ) ,2010-2013 More Information

Evering, Teresa H; Chew, Kara W; Giganti, Mark J; Moser, Carlee; Pinilla, Mauricio; Wohl, David Alain; Currier, Judith S; Eron, Joseph J; Javan, Arzhang Cyrus; Bender Ignacio, Rachel; Margolis, David; Zhu, Qing; Ma, Ji; Zhong, Lijie; Yan, Li; D'Andrea Nores, Ulises; Hoover, Keila; Mocherla, Bharat; Choudhary, Manish C; Deo, Rinki; Ritz, Justin; Fischer, William A; Fletcher, Courtney V; Li, Jonathan Z; Hughes, Michael D; Smith, Davey; Daar, Eric S (2023. ) Safety and Efficacy of Combination SARS-CoV-2 Neutralizing Monoclonal Antibodies Amubarvimab Plus Romlusevimab in Nonhospitalized Patients With COVID-19.Annals of internal medicine, , 176 (5 ) ,658-666 More Information

Kolossváry, Márton; deFilippi, Chris; McCallum, Sara; Fitch, Kathleen V; Diggs, Marissa R; Fulda, Evelynne S; Ribaudo, Heather J; Fichtenbaum, Carl J; Aberg, Judith A; Malvestutto, Carlos D; Currier, Judith S; Casado, Jose L; Gutiérrez, Félix; Sereti, Irini; Douglas, Pamela S; Zanni, Markella V; Grinspoon, Steven K (2023. ) Identification of pre-infection markers and differential plasma protein expression following SARS-CoV-2 infection in people living with HIV.EBioMedicine, , 90 ,104538 More Information

Atehortua, Laura; Baig, Mirza; Morris, Jamie; Trentman, Sarah; Davidson, W Sean; Fichtenbaum, Carl J; Chougnet, Claire A (2023. ) Impaired response of memory Treg to high density lipoproteins is associated with intermediate/high cardiovascular disease risk in persons with HIV.Frontiers in immunology, , 14 ,1146624 More Information

Schnittman, Samuel R; Jung, Wonyeong; Fitch, Kathleen V; Zanni, Markella V; McCallum, Sara; Lee, Jessica Shih-Lu; Shin, Sally; Davis, Brandon J; Fulda, Evelynne S; Diggs, Marissa R; Giguel, Francoise; Chinchay, Romina; Sheth, Anandi N; Fichtenbaum, Carl J; Malvestutto, Carlos; Aberg, Judith A; Currier, Judith; Lauffenburger, Douglas A; Douglas, Pamela S; Ribaudo, Heather J; Alter, Galit; Grinspoon, Steven K (2023. ) Effect of host factors and COVID-19 infection on the humoral immune repertoire in treated HIV.JCI insight, , 8 (5 ) , More Information

Schnittman, Samuel R; Kitch, Douglas W; Swartz, Talia H; Burdo, Tricia H; Fitch, Kathleen V; McCallum, Sara; Flynn, Jacqueline M; Fulda, Evelynne S; Diggs, Marissa R; Stapleton, Jack T; Casado, José L; Taron, Jana; Currier, Judith S; Zanni, Markella V; Malvestutto, Carlos; Fichtenbaum, Carl J; Aberg, Judith A; Ribaudo, Heather J; Lu, Michael T; Douglas, Pamela S; Grinspoon, Steven K (2023. ) Coronary Artery Plaque Composition and Severity Relate to the Inflammasome in People With Treated Human Immunodeficiency Virus.Open forum infectious diseases, , 10 (3 ) ,ofad106 More Information

Fichtenbaum, Carl J; Mallon, Patrick (2023. ) Are we ready to RESPOND that the question of abacavir's role in cardiovascular disease events is settled?.AIDS (London, England), , 37 (3 ) ,541-543 More Information

Douglas, Pamela S; McCallum, Sara; Lu, Michael T; Umbleja, Triin; Fitch, Kathleen V; Foldyna, Borek; Zanni, Markella V; Fulda, Evelynne S; Bloomfield, Gerald S; Fichtenbaum, Carl J; Overton, Edgar T; Aberg, Judith A; Malvestutto, Carlos D; Burdo, Tricia H; Arduino, Roberto C; Ho, Ken S; Yin, Michael T; Ribaudo, Heather J; Grinspoon, Steven K (2023. ) Ideal cardiovascular health, biomarkers, and coronary artery disease in persons with HIV.AIDS (London, England), , 37 (3 ) ,423-434 More Information

Schnittman, Samuel R; Lu, Michael T; Mayrhofer, Thomas; Burdo, Tricia H; Fitch, Kathleen V; McCallum, Sara; Fulda, Evelynne S; Zanni, Markella V; Foldyna, Borek; Malvestutto, Carlos; Fichtenbaum, Carl J; Aberg, Judith A; Bloomfield, Gerald S; Overton, Edgar T; Currier, Judith; Tebas, Pablo; Sha, Beverly E; Ribaudo, Heather J; Flynn, Jacqueline M; Douglas, Pamela S; Erlandson, Kristine M; Grinspoon, Steven K (2023. ) Cytomegalovirus Immunoglobulin G (IgG) Titer and Coronary Artery Disease in People With Human Immunodeficiency Virus (HIV).Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , 76 (3 ) ,e613-e621 More Information

Zanni, Markella V; Foldyna, Borek; McCallum, Sara; Burdo, Tricia H; Looby, Sara E; Fitch, Kathleen V; Fulda, Evelynne S; Autissier, Patrick; Bloomfield, Gerald S; Malvestutto, Carlos D; Fichtenbaum, Carl J; Overton, Edgar T; Aberg, Judith A; Erlandson, Kristine M; Campbell, Thomas B; Ellsworth, Grant B; Sheth, Anandi N; Taiwo, Babafemi; Currier, Judith S; Hoffmann, Udo; Lu, Michael T; Douglas, Pamela S; Ribaudo, Heather J; Grinspoon, Steven K (2023. ) Sex Differences in Subclinical Atherosclerosis and Systemic Immune Activation/Inflammation Among People With Human Immunodeficiency Virus in the United States.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , 76 (2 ) ,323-334 More Information

Mena Lora, Alfredo J; Long, Jessica E; Huang, Yunda; Baden, Lindsey R; El Sahly, Hana M; Follmann, Dean; Goepfert, Paul; Gray, Glenda; Grinsztejn, Beatriz; Kotloff, Karen; Rouphael, Nadine; Sobieszczyk, Magdelena; Walsh, Stephen R; Andriesen, Jessica; Shah, Karan A; Zhang, Yuanyuan; Gilbert, Peter; Janes, Holly; Gay, Cynthia L; Falsey, Ann R; Tripp, Rebecca L; Gorman, Richard L; Tong, Tina; Marovich, Mary; Neuzil, Kathleen; Corey, Lawrence; Kublin, James G (2023. ) Rapid Development of an Integrated Network Infrastructure to Conduct Phase 3 COVID-19 Vaccine Trials.JAMA network open, , 6 (1 ) ,e2251974 More Information

Fulda, Evelynne S; Fichtenbaum, Carl J; Kileel, Emma M; Zanni, Markella V; Aberg, Judith A; Malvestutto, Carlos; Cardoso, Sandra Wagner; Berzins, Baiba; Lira, Rita; Harden, Regina; Robbins, Gregory; Martinez, Maria; Nieves, Sylvia Davila; McCallum, Sara; Cruz, Jorge Leon; Umbleja, Triin; Sprenger, Heather; Giguel, Francoise; Bone, Frederic; Wood, Ken; Byroads, Mark; Paradis, Kayla; Lu, Michael T; Douglas, Pamela S; Ribaudo, Heather J; Grinspoon, Steven K; Fitch, Kathleen V (2023. ) The importance of methods for site performance evaluation in REPRIEVE, a longitudinal, global, multicenter trial.Contemporary clinical trials, , 124 ,107035 More Information

Feria, Manuel G; Chang, Cecilia; Ticona, Eduardo; Moussa, Anissa; Zhang, Bin; Ballena, Isabel; Azañero, Ruben; Ticona, Cesar; De Cecco, Carlo N; Fichtenbaum, Carl J; O'Donnell, Robert E; La Rosa, Alberto; Sanchez, Jorge; Andorf, Sandra; Atehortua, Laura; Katz, Jonathan D; Chougnet, Claire A; Deepe, George S; Huaman, Moises A (2022. ) Pro-Inflammatory Alterations of Circulating Monocytes in Latent Tuberculosis Infection.Open forum infectious diseases, , 9 (12 ) ,ofac629 More Information

Fitch, Kathleen V; McCallum, Sara A; Erlandson, Kristine M; Overton, Edgar Turner; Zanni, Markella V; Fichtenbaum, Carl; Aberg, Judith A; Fulda, Evelynne S; Kileel, Emma M; Moran, Laura E; Bloomfield, Gerald S; Novak, Richard M; Pérez-Frontera, Sigrid; Abrams-Downey, Alexandra; Pierone, Gerald; Kumarasamy, Nagalingeswaran; Ruxrungtham, Kiat; Mngqibisa, Rosie; Douglas, Pamela S; Ribaudo, Heather J; Grinspoon, Steven K (2022. ) Diet in a global cohort of adults with HIV at low-to-moderate traditional cardiovascular disease risk.AIDS (London, England), , 36 (14 ) ,1997-2003 More Information

Kolossváry, Márton; deFilippi, Chris; Lu, Michael T; Zanni, Markella V; Fulda, Evelynne S; Foldyna, Borek; Ribaudo, Heather; Mayrhofer, Thomas; Collier, Ann C; Bloomfield, Gerald S; Fichtenbaum, Carl; Overton, Edgar T; Aberg, Judith A; Currier, Judith; Fitch, Kathleen V; Douglas, Pamela S; Grinspoon, Steven K (2022. ) Proteomic Signature of Subclinical Coronary Artery Disease in People With HIV: Analysis of the REPRIEVE Mechanistic Substudy.The Journal of infectious diseases, , 226 (10 ) ,1809-1822 More Information

Looby, Sara E; Kantor, Amy; Burdo, Tricia H; Currier, Judith S; Fichtenbaum, Carl J; Overton, Edgar T; Aberg, Judith A; Malvestutto, Carlos D; Bloomfield, Gerald S; Erlandson, Kristine M; Cespedes, Michelle; Kallas, Esper G; Masiá, Mar; Thornton, Alice C; Smith, Mandy D; Flynn, Jacqueline M; Kileel, Emma M; Fulda, Evelynne; Fitch, Kathleen V; Lu, Michael T; Douglas, Pamela S; Grinspoon, Steven K; Ribaudo, Heather J; Zanni, Markella V (2022. ) Factors Associated With Systemic Immune Activation Indices in a Global Primary Cardiovascular Disease Prevention Cohort of People With Human Immunodeficiency Virus on Antiretroviral Therapy.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , 75 (8 ) ,1324-1333 More Information

Erlandson, Kristine M; Fitch, Kathleen V; McCallum, Sara A; Ribaudo, Heather J; Overton, Edgar T; Zanni, Markella V; Bloomfield, Gerald S; Brown, Todd T; Fichtenbaum, Carl J; Bares, Sara; Aberg, Judith A; Douglas, Pamela S; Fulda, Evelynne S; Santana-Bagur, Jorge L; Castro, Jose G; Moran, Laura E; Mave, Vidya; Supparatpinyo, Khuanchai; Ponatshego, Ponego L; Schechter, Mauro; Grinspoon, Steven K (2022. ) Geographical Differences in the Self-Reported Functional Impairment of People With Human Immunodeficiency Virus (HIV) and Associations With Cardiometabolic Risk.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, , 75 (7 ) ,1154-1163 More Information

Hagey, Rachel J; Elazar, Menashe; Pham, Edward A; Tian, Siqi; Ben-Avi, Lily; Bernardin-Souibgui, Claire; Yee, Matthew F; Moreira, Fernando R; Rabinovitch, Meirav Vilan; Meganck, Rita M; Fram, Benjamin; Beck, Aimee; Gibson, Scott A; Lam, Grace; Devera, Josephine; Kladwang, Wipapat; Nguyen, Khanh; Xiong, Anming; Schaffert, Steven; Avisar, Talia; Liu, Ping; Rustagi, Arjun; Fichtenbaum, Carl J; Pang, Phillip S; Khatri, Purvesh; Tseng, Chien-Te; Taubenberger, Jeffery K; Blish, Catherine A; Hurst, Brett L; Sheahan, Timothy P; Das, Rhiju; Glenn, Jeffrey S (2022. ) Programmable antivirals targeting critical conserved viral RNA secondary structures from influenza A virus and SARS-CoV-2.Nature medicine, , 28 (9 ) ,1944-1955 More Information

Overton, Edgar T; Weir, Isabelle R; Zanni, Markella V; Fischinger, Stephanie; MacArthur, Rodger D; Aberg, Judith A; Fitch, Kathleen V; Frank, Michael; Albrecht, Helmut; Goodenough, Elliot; Rhame, Frank S; Fichtenbaum, Carl J; Bloomfield, Gerald S; Malvestutto, Carlos; Supparatpinyo, Khuanchai; McCallum, Sara; Douglas, Pamela S; Alter, Galit; Ribaudo, Heather; Grinspoon, Steven K (2022. ) Asymptomatic SARS-CoV-2 Infection Is Common Among ART-Treated People With HIV.Journal of acquired immune deficiency syndromes (1999), , 90 (4 ) ,377-381 More Information

Bloomfield, Gerald S; Weir, Isabelle R; Ribaudo, Heather J; Fitch, Kathleen V; Fichtenbaum, Carl J; Moran, Laura E; Bedimo, Roger; de Filippi, Christopher; Morse, Caryn G; Piccini, Jonathan; Zanni, Markella V; Lu, Michael T; Hoffmann, Udo; Grinspoon, Steven K; Douglas, Pamela S (2022. ) Prevalence and Correlates of Electrocardiographic Abnormalities in Adults With HIV: Insights From the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE).Journal of acquired immune deficiency syndromes (1999), , 89 (3 ) ,349-359 More Information

Fulda, Evelynne S; Fitch, Kathleen V; Overton, Edgar T; Zanni, Markella V; Aberg, Judith A; Currier, Judith S; Lu, Michael T; Malvestutto, Carlos; Fichtenbaum, Carl J; Martinez, Esteban; Umbleja, Triin; Douglas, Pamela S; Ribaudo, Heather J; Grinspoon, Steven K (2022. ) COVID-19 Vaccination Rates in a Global HIV Cohort.The Journal of infectious diseases, , 225 (4 ) ,603-607 More Information

O'Brien, Meagan P; Forleo-Neto, Eduardo; Sarkar, Neena; Isa, Flonza; Hou, Peijie; Chan, Kuo-Chen; Musser, Bret J; Bar, Katharine J; Barnabas, Ruanne V; Barouch, Dan H; Cohen, Myron S; Hurt, Christopher B; Burwen, Dale R; Marovich, Mary A; Brown, Elizabeth R; Heirman, Ingeborg; Davis, John D; Turner, Kenneth C; Ramesh, Divya; Mahmood, Adnan; Hooper, Andrea T; Hamilton, Jennifer D; Kim, Yunji; Purcell, Lisa A; Baum, Alina; Kyratsous, Christos A; Krainson, James; Perez-Perez, Richard; Mohseni, Rizwana; Kowal, Bari; DiCioccio, A Thomas; Geba, Gregory P; Stahl, Neil; Lipsich, Leah; Braunstein, Ned; Herman, Gary; Yancopoulos, George D; Weinreich, David M (2022. ) Effect of Subcutaneous Casirivimab and Imdevimab Antibody Combination vs Placebo on Development of Symptomatic COVID-19 in Early Asymptomatic SARS-CoV-2 Infection: A Randomized Clinical Trial.JAMA, , 327 (5 ) ,432-441 More Information

Guanira, Juan V; Fichtenbaum, Carl J (2022. ) Is it time to retire efavirenz as a first-line option worldwide?.AIDS (London, England), , 36 (2 ) ,317-318 More Information

Presti, Rachel M; Yeh, Eunice; Williams, Brett; Landay, Alan; Jacobson, Jeffrey M; Wilson, Cara; Fichtenbaum, Carl J; Utay, Netanya S; Dube, Michael P; Klingman, Karin L; Estes, Jacob D; Flynn, Jacob K; Loftin, Amanda; Brenchley, Jason M; Andrade, Adriana; Kitch, Douglas W; Overton, Edgar T (2021. ) A Randomized, Placebo-Controlled Trial Assessing the Effect of VISBIOME ES Probiotic in People With HIV on Antiretroviral Therapy.Open forum infectious diseases, , 8 (12 ) ,ofab550 More Information

Kileel, Emma M; Lo, Janet; Malvestutto, Carlos; Fitch, Kathleen V; Zanni, Markella V; Fichtenbaum, Carl J; Overton, Edgar T; Okeke, Nwora Lance; Kumar, Princy; Joao, Esau; Aberg, Judith A; Martinez, Esteban; Currier, Judith S; Douglas, Pamela S; Ribaudo, Heather J; Grinspoon, Steven K (2021. ) Assessment of Obesity and Cardiometabolic Status by Integrase Inhibitor Use in REPRIEVE: A Propensity-Weighted Analysis of a Multinational Primary Cardiovascular Prevention Cohort of People With Human Immunodeficiency Virus.Open forum infectious diseases, , 8 (12 ) ,ofab537 More Information

Karady, Julia; Lu, Michael T; Bergström, Göran; Mayrhofer, Thomas; Taron, Jana; Foldyna, Borek; Paradis, Kayla; McCallum, Sara; Aberg, Judith A; Currier, Judith S; Fitch, Kathleen V; Fulda, Evelynne S; Bloomfield, Gerald S; Overton, Edgar T; Lind, Lars; Östgren, Carl Johan; Elvstam, Olof; Söderberg, Stefan; Jernberg, Tomas; Pepe, Rosalie; Dubé, Michael P; Mushatt, David; Fichtenbaum, Carl J; Malvestutto, Carlos; Zanni, Markella V; Hoffmann, Udo; Ribaudo, Heather; Grinspoon, Steven K; Douglas, Pamela S (2024. ) Coronary Plaque in People With HIV vs Non-HIV Asymptomatic Community and Symptomatic Higher-Risk Populations.JACC. Advances, , 3 (6 ) ,100968 More Information

Lake, Jordan E; Kitch, Douglas W; Kantor, Amy; Muthupillai, Raja; Klingman, Karin L; Vernon, Christina; Belaunzaran-Zamudio, Pablo F; Fichtenbaum, Carl J; Heath, Sonya; Perazzo, Hugo; Corey, Kathleen; Brown, Todd T; Landay, Alan; Sattler, Fred; Erlandson, Kristine M (2024. ) The Effect of Open-Label Semaglutide on Metabolic Dysfunction-Associated Steatotic Liver Disease in People With HIV.Annals of internal medicine, , 177 (6 ) ,835-838 More Information

Fisher, Leigh H; Kee, Jia Jin; Liu, Albert; Espinosa, Claudia M; Randhawa, April K; Ludwig, James; Magaret, Craig A; Robinson, Samuel T; Gilbert, Peter B; Hyrien, Ollivier; Kublin, James G; Rouphael, Nadine; Falsey, Ann R; Sobieszczyk, Magdalena E; El Sahly, Hana M; Grinsztejn, Beatriz; Gray, Glenda E; Kotloff, Karen L; Gay, Cynthia L; Leav, Brett; Hirsch, Ian; Struyf, Frank; Dunkle, Lisa M; Neuzil, Kathleen M; Corey, Lawrence; Huang, Yunda; Goepfert, Paul A; Walsh, Stephen R; Baden, Lindsey R; Janes, Holly (2024. ) SARS-CoV-2 Viral Load in the Nasopharynx at Time of First Infection Among Unvaccinated Individuals: A Secondary Cross-Protocol Analysis of 4 Randomized Trials.JAMA network open, , 7 (5 ) ,e2412835 More Information

Haukoos, Jason; Hopkins, Emily; Campbell, Jonathan D; Lyons, Michael S; Rothman, Richard E; Hsieh, Yu-Hsiang; White, Douglas A E; Trent, Stacy; Al-Tayyib, Alia A; Gardner, Edward M; Sabel, Allison L; Rowan, Sarah E (2024. ) Cost-Effectiveness of HIV Screening in Emergency Departments: Results From the Pragmatic Randomized HIV Testing Using Enhanced Screening Techniques in Emergency Departments Trial.Annals of emergency medicine, , More Information

1993 Peterson, LR and Fichten baum, CJ. Human Ehrlichiosis presenting as a life-threatening illness. First prize, American College of Physicians Associates Clinical Research Competition. ACP Spring Meeting, Washington DC

1992 -1994 Trainee, National Institute of Drug Abuse, Washington University

1996 John T. Carey Young Investigator Award, Adult AIDS Clinical Trials Group

2005 Top Physician, Guide to America's Top Physicians. Consumers' Research Council of America, Second Edition

2005 Top Doctors Award in Infectious Diseases, Cincinnati Magazine

2006 Top Physician, Guide to America's Top Physicians. Consumers' Research Council of America, Third Edition

2006 Top Doctors Award in Infectious Diseases, Cincinnati Magazine

2007 Health Care Heroes, Winner, Cincinnati Business Courier

2007 Top Physician, Guide to America's Top Physicians. Consumers' Research Council of America, Fourth Edition

2007 Top Doctors Award in Infectious Diseases, Cincinnati Magazine

2007 First Prize, Research Poster Competition. Bobula SM, Fichtenbaum CJ. Mismanagement of HIV-1 Infected Adults with Acute Febrile Illnesses by Cd4+ Count Risk Stratification. Ohio ACP Chapter Meeting

2008 Top Physician, Guide to America's Top Physicians. Consumers' Research Council of America, Fifth Edition

2008 Top Doctors Award in Infectious Diseases, Cincinnati Magazine

2009 Top Physician, Guide to America's Top Physicians. Consumers' Research Council of America, Sixth Edition

2009 Top Doctors Award in Infectious Diseases, Cincinnati Magazine

Infectious Diseases, AIDS-HIV, HIV Infection

Academic - UC Health Holmes Hospital
Room 3114
Cincinnati  Ohio, 45219
Phone: 513-584-6361
Fax: 513-584-6040
carl.fichtenbaum@uc.edu